Sparklight Business Launches Mobile Service for Small Businesses

Sparklight Business Mobile offers small businesses flexible, affordable mobile plans starting at $15 per month, per line, with unlimited talk and text, nationwide 5G coverage and the ability to manage up to 25 lines under one account. Learn more at business.mobile.sparklight.com.
Sparklight Business Mobile offers small businesses flexible, affordable mobile plans starting at $15 per month, per line, with unlimited talk and text, nationwide 5G coverage and the ability to manage up to 25 lines under one account. Learn more at business.mobile.sparklight.com.
  • Small businesses can choose mobile plans by employee or device
  • Two plan options support different levels of mobile data use
  • Customers can manage up to 25 mobile lines under one account
  • Sparklight Business Mobile includes unlimited talk and text and 5G nationwide coverage

PHOENIX, Nov. 03, 2026 (GLOBE NEWSWIRE) — As mobile connectivity becomes increasingly important to how small businesses operate, support employees and stay connected beyond the workplace, Sparklight Business has launched Sparklight Business Mobile, expanding its connectivity portfolio with a new wireless service designed specifically for small business customers.

Available to customers with Sparklight Business products and services, Sparklight Business Mobile offers two plan options that can be assigned by employee or device, with up to 25 lines managed under one account. Both plans include unlimited talk and text and 5G nationwide coverage.

“Small businesses need products and services that can adapt to the way their teams actually work,” said Katherine Creech, Vice President of Sparklight Business Services. “Sparklight Business Mobile gives customers the flexibility to choose the right plan for each employee or device, while making it easier to manage mobile connectivity alongside the business solutions they already rely on.”

KEY FACTS

  • Sparklight Business Mobile is available to small business customers with Sparklight Business products and services.
  • The Value Plan includes 1 GB of high-speed data for $15 per month, per line.
  • The Unlimited Plan includes 30 GB of high-speed data for $30 per month, per line.
  • Both plans include unlimited talk and text and 5G nationwide coverage.
  • Value and Unlimited plans can be used within the same business account.
  • Small businesses can manage up to 25 employee or device lines under one account.
  • Sparklight Business Mobile is a bring-your-own-device service for compatible devices, and customers can transfer eligible existing phone numbers.

Flexible Plans for Different Business Needs
Sparklight Business Mobile lets small businesses choose the Value or Unlimited Plan for each employee or device line within the same account, based on individual usage needs.

The Value Plan provides 1 GB of high-speed data for $15 per month, per line, while the Unlimited Plan provides 30 GB of high-speed data for $30 per month, per line.

Managing Mobile Service Across the Business
Small businesses can manage up to 25 mobile lines under one Sparklight Business Mobile account. Through the mobile app, customers can review usage by line and manage plans as staffing, responsibilities and mobile needs change.

The service extends an existing Sparklight Business internet relationship to mobile connectivity, giving small businesses a way to manage employee and device lines alongside their existing Sparklight business solutions.

Bringing Existing Devices and Numbers to Sparklight Business Mobile
Sparklight Business Mobile is a bring-your-own-device service for compatible devices. Customers can also transfer eligible existing phone numbers when moving lines to the service. These capabilities allow businesses to add mobile service while retaining compatible devices and established phone numbers.

A Natural Extension of Sparklight Business Connectivity
The launch of Sparklight Business Mobile expands Sparklight Business’ connectivity portfolio by adding mobile service alongside its existing internet, voice and managed services for small businesses. The new offering extends connectivity beyond the workplace to employees and business devices that need mobile service throughout the workday.

“Adding mobile service is a natural extension of how we support small businesses,” Creech said. “Our customers rely on connectivity in more places than ever, and Sparklight Business Mobile gives them another way to keep their teams connected while managing services through a provider they already know and trust.”

Small businesses can explore Sparklight Business Mobile plans and get started at business.mobile.sparklight.com. For more information about Sparklight Business connectivity solutions, visit business.sparklight.com or call 888-251-6201.

Frequently Asked Questions

Question: Who is Sparklight Business Mobile for?
Answer: Sparklight Business Mobile is designed for small business customers. To add mobile service, businesses must have an active Sparklight Business account.

Question: How much does Sparklight Business Mobile cost?

Answer: The Value Plan costs $15 per month, per line, and includes 1 GB of high-speed data. The Unlimited Plan costs $30 per month, per line and includes 30 GB of high-speed data.

Question: Can I put different employees on different mobile plans?
Answer: Yes. Small businesses can mix and match Value and Unlimited plans within the same account based on the mobile data needs of individual employees or devices.

Question: Can I bring my own phone and keep my existing number?
Answer: Yes. Sparklight Business Mobile supports bring-your-own-device service for compatible devices, and customers can transfer eligible existing phone numbers when moving lines to the service.

Question: How many mobile lines can my small business have?
Answer: Small businesses can manage up to 25 employee or business device lines under one Sparklight Business Mobile account.

Question: Does Sparklight Business Mobile include 5G nationwide coverage?
Answer: Yes. Both Sparklight Business Mobile plans include 5G nationwide coverage.

Additional Resources

About Sparklight Business
Sparklight Business provides customized connectivity solutions for organizations of all sizes — spanning high-speed internet, voice and managed services for small businesses to scalable fiber, Ethernet and high-capacity network solutions with speeds up to 10 Gig and beyond for enterprise, carrier and wholesale partners.

CONTACT:
Trish Niemann
Vice President, Communications Strategy
trish.niemann@cableone.biz

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1f127616-b0e3-4440-83d8-ba7bf78abe17

MONTREAL, Nov. 03, 2026 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX:SJ).

Open to: Investors, analysts and all interested parties
Date: Wednesday, November 4, 2026
Time: 10:00 AM Eastern Standard Time (EST)
Live Webcast: https://meetings.lumiconnect.com/400-423-513-760
Call: Local – Toronto: +1 (416) 855-9085 
Toll Free – North America: +1 (800) 990-2777 
Conference ID: 62617


The press release will be published before market opens the day of the conference call through Globe Newswire.
Please log on or dial in 15 minutes before the conference begins.

If you are unable to attend at this time, you may access a web recording of the meeting at the following link: https://meetings.lumiconnect.com/400-423-513-760. This recording will be available on Wednesday, November 4, 2026 as of 1:00 PM EST until 11:59 PM EST on Wednesday, November 11, 2026.

Media wishing to quote an analyst should contact the analyst personally for permission.

About Stella-Jones

Stella-Jones Inc. (TSX: SJ) is a leading North American manufacturer of products focused on supporting infrastructure essential to the electrical distribution and transmission network, and the operation and maintenance of railway transportation systems. It supplies the continent’s major electrical utility companies with treated wood poles and crossarms, steel lattice towers and steel transmission poles, as well as North America’s Class 1, short line and commercial railroad operators with treated wood railway ties. It also supports infrastructure with industrial products, namely timbers for railway bridges, crossings and construction, marine and foundation pilings, and coal tar-based products. Additionally, the Company manufactures and distributes premium treated residential lumber and accessories to Canadian and American retailers for outdoor applications, with a significant portion of the business devoted to servicing Canadian customers through its national manufacturing and distribution network.

Stella-Jones – Head Office
3100 de la Côte-Vertu Blvd., # 300
Saint-Laurent, Québec H4R 2J8
Tel.: (514) 934-8666
Fax: (514) 934-5327
 


Contact

Investor Relations
David Galison
Vice-President, Investor Relations
Tel.: (647) 618-2709
dgalison@stella-jones.com
Media
Stephanie Corrente
Director, Corporate Communications
Tel.: (514) 934-8666
communications@stella-jones.com

Includes 9 Metres Averaging 3.23% Cu and 16.7 g/t Ag

MONTREAL, Nov. 03, 2026 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals”) (TSX: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce new analytical results from the ongoing 2026 drill program at the Gaspé Copper Project, located in the Gaspé Peninsula of Eastern Québec. Results are presented below (see Table 1), and include 38 mineralized intercepts from 15 drill holes. Reported “infill” intercepts are located within the 2026 MRE model (see April 14, 2026 news release), focused on upgrading Inferred Mineral Resources to Measured or Indicated categories, as applicable. “Expansion” intercepts are located outside the 2026 MRE model and comprise either i) in-pit expansion, which offers potential to convert in-pit waste into additional resources within the 2026 MRE Whittle pit; or ii) out-of-pit expansion, consisting of mineralization located outside the 2026 MRE Whittle pit, which may potentially lead to the definition of new resources. Some of the reported intercepts may have contiguous shallower infill as well as deeper in-pit expansion (noted as “Both”). Maps showing hole locations are available at www.osiskometals.com.

Osisko Metals Chief Executive Officer Robert Wares commented: “Today’s results, particularly drill holes 30-1270 and 30-1272, show once again strong results from the southern end of the 2026 MRE model. Furthermore, drill hole 30-1260, which is the most southerly hole drilled to date at Needle Mountain (out-of-pit expansion), located approximately 400 metres southwest of the current 2026 MRE pit boundary, returned 121 metres averaging 0.42% Cu at the level of the B and C Zones, indicating the system continues to be well mineralized and open to the south.”

20261103 Osisko Metals news release Figure 1/plan view

20261103 Osisko Metals news release Figure 2/long section

Highlights

  • 314.0 metres averaging 0.44% Cu (infill) in DDH 30-1272; includes 9.0 metres averaging 3.23% Cu and 16.7 g/t Ag
  • 240.5 metres averaging 0.44% Cu (infill) in DDH 30-1270
  • 552.5 metres averaging 0.30% Cu (infill) in DDH 30-1269
  • 142.6 metres averaging 0.34% Cu (infill) in DDH 30-1274
  • 121.5 metres averaging 0.42% Cu (out-of-pit expansion) in DDH 30-1260
  • 87.5 metres averaging 0.48% Cu (out-of-pit expansion) in DDH 30-1268; includes 10.7 metres averaging 1.98% Cu and 9.0 g/t Ag
  • 85.5 metres averaging 0.42% Cu (out-of-pit expansion) in DDH 30-1265

Table 1: Infill and Expansion Drilling Results

DDH No. From (m) To (m) Length (m) Cu % Ag g/t Mo % CuEq* % Type**
30-1260 301.5 423.0 121.5 0.42 2.39 <0.005 0.42 Expansion 2
30-1261 10.3 37.5 27.2 0.22 2.47 <0.005 0.22 Infill
and 61.5 217.8 156.3 0.20 1.57 <0.005 0.20 Infill
and 240.0 454.2 214.2 0.24 1.72 0.012 0.28 Infill
and 502.5 551.2 48.7 0.12 1.12 0.022 0.20 Infill
and 574.1 664.1 90.0 0.35 2.58 0.007 0.37 Infill
30-1262 18.0 109.0 91.0 0.26 2.55 0.005 0.28 Both
and 137.0 153.0 16.0 0.40 3.40 <0.005 0.40 Expansion 1
and 230.8 267.0 36.2 0.23 1.98 <0.005 0.23 Expansion 2
30-1263 59.0 120.0 61.0 0.17 1.67 <0.005 0.17 Infill
and 220.5 264.0 43.5 0.33 2.65 <0.005 0.34 Infill
and 319.7 343.5 23.8 0.35 2.54 <0.005 0.35 Infill
30-1264 18.0 36.0 18.0 0.76 4.43 <0.005 0.77 Infill
and 62.0 363.0 301.0 0.22 1.69 0.006 0.24 Infill
and 420.0 445.5 25.5 0.62 4.96 <0.005 0.63 Infill
and 492.0 591.0 99.0 0.40 2.46 0.018 0.46 Infill
30-1265 12.0 44.0 32.0 0.54 3.96 <0.005 0.55 Expansion 1
and 75.0 136.4 61.4 0.27 2.43 <0.005 0.28 Expansion 1
and 161.6 174.0 12.4 0.83 7.30 0.009 0.87 Expansion 1
and 199.5 285.0 85.5 0.42 4.04 <0.005 0.43 Expansion 2
30-1266 103.6 121.5 17.9 0.20 1.25 <0.005 0.20 Expansion 1
and 151.5 184.5 33.0 0.41 2.63 <0.005 0.41 Expansion 2
30-1267 105.0 178.5 73.5 0.18 1.73 0.005 0.20 Infill
and 211.5 243.0 31.5 0.12 1.90 0.013 0.16 Infill
and 330.0 426.0 96.0 0.23 1.73 0.008 0.26 Infill
and 444.0 573.0 129.0 0.17 1.48 0.014 0.22 Infill
30-1268 261.0 348.5 87.5 0.48 2.71 <0.005 0.49 Expansion 2
(including) 281.8 292.5 10.7 1.98 9.01 0.005 2.01 Expansion 2
and 381.6 400.5 18.9 0.33 2.84 <0.005 0.33 Expansion 2
30-1269 13.0 83.0 70.0 0.24 1.65 <0.005 0.24 Infill
and 106.0 658.5 552.5 0.30 2.33 0.012 0.35 Infill
(including) 210.7 221.0 10.3 1.35 8.42 0.007 1.38 Infill
30-1270 58.0 298.5 240.5 0.44 4.47 <0.005 0.45 Infill
30-1271 20.0 198.0 178.0 0.23 2.01 0.006 0.25 Infill
and 232.5 354.0 121.5 0.31 2.51 <0.005   Infill
30-1272 43.0 357.0 314.0 0.44 3.61 <0.005 0.45 Infill
(including) 285.0 294.0 9.0 3.23 16.7 <0.005 3.25 Infill
30-1273 Lost hole in stope – no significant mineralization
30-1274 5.0 92.0 87.0 0.33 1.73 <0.005 0.33 Infill
and 114.0 291.0 177.0 0.18 1.58 0.005 0.19 Infill
and 337.5 546.0 208.5 0.18 1.72 0.014 0.23 Infill
and 613.8 756.4 142.6 0.34 2.00 0.020 0.42 Infill
                 

* See explanatory notes below on copper equivalent values and Quality Assurance/Quality Controls.
** Infill refers to intercepts within the current MRE model; Expansion 1 refers to in-pit intercepts outside of the current MRE model; Expansion 2 refers to out-of-pit intercepts outside of the current MRE model. “Both” indicates drill holes that have contiguous shallower infill as well as deeper in-pit expansion intercepts.

Additional comments

Drill holes 30-1260 and 30-1268 are located on the north flank of Needle Mountain near its peak, with 30-1260 being the most southerly hole drilled to date on Needle Mountain. Hole 30-1260 was a vertical hole that intersected 121.5 metres averaging 0.42% Cu and 2.39 g/t Ag at the level of the B and C Zone skarns, including the intervening porcellanites. Drill hole 30-1268 is a westerly inclined hole that intersected 87.5 metres averaging 0.48% Cu and 2.71 g/t Ag, also at the level of the B and C Zone skarns. Both holes indicate that the mineralized system at Needle Mountain remains open to the south.

Drill hole 30-1266 is a westerly inclined hole located along the northeast margin of the Needle Mountain pit. It intersected two short intervals of mineralization, including 33.0 metres averaging 0.41% Cu and 2.63 g/t Ag.

Drill hole 30-1265 is a vertical hole located just south of the southern limit of the 2026 MRE model. It intersected four intervals of mineralization, 12.4 to 85.5 metres long, averaging 0.27 to 0.83% Cu and 2.43 to 7.30 g/t Ag, the last interval representing a significant out-of-pit expansion.

Drill holes 30-1262, 30-1270 and 30-1272 are all infill holes located near the southern margin of the 2026 MRE model. Hole 30-1262 is westerly inclined that expanded the mineralized envelope to the west, while 30-1270 and 30-1272 drilled through pillars of both the B Zone and C Zone underground workings, returning continuous well-mineralized intervals of 240.5 and 314.0 metres, respectively, averaging 0.44% Cu.

Drill holes 30-1261, 30-1263, 30-1264, 30-1267, 30-1269, 30-1271 and 30-1274 are all vertical to near-vertical infill holes located on the south flank of Copper Mountain. All returned multiple mineralized intervals that graded in a range of 0.12% to 0.40% Cu, all within values anticipated from the 2026 MRE model.

Mineralization at Gaspé Copper is of porphyry copper/skarn type and occurs as disseminations and stockworks of chalcopyrite with pyrite or pyrrhotite and minor bornite and molybdenite. One prograde and at least five retrograde vein/stockwork mineralizing events have been recognized at Copper Mountain, which overprint earlier, stratiform, carbonate replacement skarn and porcellanite-hosted mineralization throughout the Gaspé Copper system. Porcellanite is a historical mining term used to describe bleached, pale green to white potassic-altered hornfels. Subvertical stockwork mineralization dominates at Copper Mountain whereas prograde bedding-parallel mineralization, which is mostly stratigraphically controlled, dominates in the area of lower Copper Mountain, Needle Mountain, Needle East, and Copper Brook. High molybdenum grades (up to 0.5% Mo) were locally obtained in both the C Zone and E Zone skarns away from Copper Mountain.

The 2022 to 2024 Osisko Metals drill programs were focused on defining open-pit resources within the Copper Mountain stockwork mineralization (see May 6, 2024 MRE press release). Extending the resource model south of Copper Mountain into the poorly-drilled prograde skarn/porcellanite portion of the system subsequently led to a significantly increased resource, mostly in the Inferred category (see November 14, 2024 MRE press release), and additional drilling in 2025 led to an additional significant increase in resources, mostly in the Measured and Indicated categories (see April 14, 2026 MRE press release).

The current drill program is designed to convert the bulk of the remaining 2026 MRE Inferred resources to Measured and Indicated categories, as well as test the expansion of the overall resource laterally to the west, and to the south/southwest towards Needle East and Needle Mountain respectively.

Table 2: Drill hole locations

DDH No. Azi. (°) Dip (°) Length (m) UTM E UTM N Elevation
30-1260 0 -90 465 315821 5424690 869
30-1261 0 -90 678 316166 5425858 589
30-1262 260 -75 300 316254 5425289 636
30-1263 0 -90 429 316579 5425886 603
30-1264 0 -90 621 316328 5425765 576
30-1265 0 -90 300 316278 5425220 667
30-1266 255 -65 318 315849 5425345 681
30-1267 0 -90 585 316449 5426128 668
30-1268 255 -88 441 315876 5424829 818
30-1269 0 -90 684 316306 5425844 592
30-1270 0 -90 366 316343 5425370 635
30-1271 178 -78 612 316414 5425736 574
30-1272 42 -84 381 316497 5425361 643
30-1273 0 -90 117 315617 5425547 653
30-1274 5 -85 828 316354 5425910 612
             

Explanatory note regarding copper-equivalent grades

Copper Equivalent (CuEq) grades are presented for illustrative purposes only to express the combined value of copper, molybdenum, and silver as a single copper grade. CuEq grades are calculated using long-term metal prices of US$4.50/lb copper, US$20.00/lb molybdenum, and US$45.00/oz silver, and incorporate assumptions for metallurgical recoveries, payable metal factors, smelting and refining charges, transportation costs, and royalties. Hence the CuEq calculation is essentially based on net smelter return (NSR) values. NSR for each metal is estimated by applying metallurgical recoveries, payable factors, metal prices, and applicable smelting, refining, transportation, and penalty charges to the in-situ metal grades. CuEq grades are derived using a linear regression relationship established between copper grade and copper NSR, and then calculated by substituting total NSR (Cu + Mo + Ag) for copper NSR in the regression equation. The simplified formula is expressed as CuEq (%) = Cu (%) + 3.40327 × Mo (%) + 0.00008 × Ag (g/t).

Qualified Person

The scientific and technical content of this news release has been reviewed and approved by Mr. Bernard-Olivier Martel, P. Geo. (OGQ 492), an independent “qualified person” as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”).

Quality Assurance / Quality Control

Mineralized intervals reported herein are calculated using an average 0.12% CuEq lower cut-off over contiguous 20-metre intersections (shorter intervals as the case may be at the upper and lower limits of reported intervals). Intervals of 10 metres or less are generally not reported unless considered material. True widths are estimated at 80 – 90 % of the reported core length intervals.

Osisko Metals adheres to a strict QA/QC program for core handling, sampling, sample transportation and analyses, including insertion of blanks and standards in the sample stream. Drill core is drilled in HQ or NQ diameter and securely transported to its core processing facility on site, where it is logged, cut and sampled. Samples selected for assay are sealed and shipped to ALS Canada Ltd.’s preparation facility in Sudbury. Sample preparation details (code PREP-31DH) are available on the ALS Canada website. Pulps are analyzed at the ALS Canada Ltd. facility in North Vancouver, BC. All samples are analyzed by four acid digestion followed by both ICP-AES and ICP-MS for Cu, Mo and Ag.

About Osisko Metals

Osisko Metals Incorporated is a Canadian exploration and development company creating value in the critical metals sector, with a focus on copper and zinc. The Company acquired a 100% interest in the past-producing Gaspé Copper mine from Glencore Canada Corporation in July 2023. The Gaspé Copper mine site is located near Murdochville in Québec’s Gaspé Peninsula. The Company is currently focused on resource expansion of the Gaspé Copper deposits, with current pit-constrained Measured and Indicated Mineral Resources of 1.83 Bt averaging 0.32% CuEq and Inferred Mineral Resources of 239 Mt averaging 0.46% CuEq (in compliance with NI 43-101). For more information, see Osisko Metals’ April 14, 2026 news release entitled “Osisko Metals Announces Significant Increase in Mineral Resource at Gaspé Copper”. Gaspé Copper hosts the largest undeveloped copper resource in eastern North America, strategically located near existing infrastructure in the mining-friendly province of Québec.

In addition to the Gaspé Copper project, the Company is working with Appian Capital Advisory LLP through the Pine Point Mining Limited joint venture to advance one of Canada‘s largest past-producing zinc mining camps, the Pine Point project, located in the Northwest Territories. The current mineral resource estimate for the Pine Point project consists of Indicated Mineral Resources of 49.5 Mt averaging 5.52% ZnEq and Inferred Mineral Resources of 8.3 Mt averaging 5.64% ZnEq (in compliance with NI 43-101). For more information, see Osisko Metals‘ June 25, 2024 news release entitled “Osisko Metals releases Pine Point mineral resource estimate: 49.5 million tonnes of indicated resources at 5.52% ZnEq”. The Pine Point project is located on the south shore of Great Slave Lake, NWT, close to infrastructure, with paved road access, an electrical substation and 100 kilometres of viable haul roads.

For further information on this news release, visit www.osiskometals.com or contact:

Don Njegovan, President
Email: info@osiskometals.com
Phone: (416) 500-4129

Cautionary Statement on Forward-Looking Information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Any statement that involves predictions, expectations, interpretations, beliefs, plans, projections, objectives, assumptions, future events or performance (often, but not always, using phrases such as “expects”, or “does not expect”, “is expected”, “interpreted”, “management’s view”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “potential”, “feasibility”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken, occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information. This news release contains forward-looking information pertaining to, among other things: the tax treatment of the FT Units; the timing of incurring the Qualifying Expenditures and the renunciation of the Qualifying Expenditures; the ability to advance Gaspé Copper to a construction decision (if at all); the ability to increase the Company’s trading liquidity and enhance its capital markets presence; the potential re-rating of the Company; the ability for the Company to unlock the full potential of its assets and achieve success; the ability for the Company to create value for its shareholders; the advancement of the Pine Point project; the anticipated resource expansion of the Gaspé Copper system and Gaspé Copper hosting the largest undeveloped copper resource in eastern North America.

Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management, in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including, without limitation, assumptions about: the ability of exploration results, including drilling, to accurately predict mineralization; errors in geological modelling; insufficient data; equity and debt capital markets; future spot prices of copper and zinc; the timing and results of exploration and drilling programs; the accuracy of mineral resource estimates; production costs; political and regulatory stability; the receipt of governmental and third party approvals; licenses and permits being received on favourable terms; sustained labour stability; stability in financial and capital markets; availability of mining equipment and positive relations with local communities and groups. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information are set out in the Company’s public disclosure record on SEDAR+ (www.sedarplus.ca) under Osisko Metals’ issuer profile. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward- looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/03f3393f-1256-4ca8-a3c7-bd04946a7590

https://www.globenewswire.com/NewsRoom/AttachmentNg/c98645b3-59cf-4277-bbb4-dcd20f35faf4

According to a recent Equifax survey, rising costs are changing how Canadians are managing their credit, with younger adults and families facing mounting financial impact

TORONTO, Nov. 03, 2026 (GLOBE NEWSWIRE) — Nearly half (49 per cent) of Canadians surveyed aged 18 to 34 worry their financial health and credit score could affect a major financial milestone in the next 12 months, according to a new Equifax Canada* Financial Literacy survey. That compares with 31 per cent of those aged 35 to 54 and just 11 per cent of Canadians aged 55 and older.

From qualifying for a mortgage to securing a rental apartment or financing a vehicle, younger Canadians are focused on how their financial health and credit scores could influence important financial decisions. Nationally, more than one in four Canadians (27 per cent) are worried about their financial health and credit scores affecting at least one financial milestone, rising to 41 per cent among households with children under 18.

The survey also found that 42 per cent of respondents say evolving financial goals have prompted them to take a more proactive role in managing their credit score. That figure rises to 59 per cent among Canadians aged 18 to 34 and 55 per cent among households with children.

“Understanding the components that impact a consumer’s credit score can help empower Canadians to plan for life’s biggest financial decisions, from finding a place to live to accessing the most favorable credit terms,” said Rebecca Oakes, Vice President of Advanced Analytics at Equifax Canada. “Younger Canadians are recognizing the importance of trying to establish better financial habits early on as everyday expenses are putting pressure on household budgets. Understanding how to build credit and taking steps to maintain a healthy credit history can help consumers better prepare for important financial decisions.”

Financial Challenges Vary Across Households and Regions
The survey found that nearly one in five Canadians (19 per cent) say they have a strong credit score, but are struggling to cover their expenses. That figure rises to 25 per cent among households with children under 18.

More broadly, while 39 per cent of Canadians say they can comfortably cover their expenses and have money left over, another 37 per cent can cover their expenses but have little or no money remaining.

Other findings highlight the financial pressures facing Canadian households:

  • 15 per cent sometimes or regularly use credit or borrow money to cover essential expenses, rising to 21 per cent among Canadians aged 18 to 34 and households with children.
  • 15 per cent are taking proactive steps to safeguard their credit standing amidst changing economic conditions.
  • 17 per cent say rising costs have prompted them to focus more on managing their credit score, while 10 per cent report becoming less focused on it.
  • 17 per cent know what they need to do to improve their credit score but say their financial circumstances prevent them from doing so.

Atlantic Canadians report some of the greatest financial challenges, with nearly one in four respondents (24 per cent) saying they sometimes or regularly use credit or borrow money to cover essential expenses, compared with 15 per cent nationally. The region also reports elevated concerns about financial health affecting vehicle financing (19 per cent) and mortgage qualification or renewal (17 per cent), compared with 10 per cent and 11 per cent nationally, respectively.

In Ontario, nearly one in three consumers who responded (32 per cent) worry their financial health could affect a major financial milestone in the next 12 months, compared with 27 per cent nationally. Meanwhile, 18 per cent of Ontarians report relying on credit or borrowing to cover essential expenses.

Building Credit Awareness for Long-Term Growth

  • 21 per cent of Canadians surveyed aged 18 to 34 are focused on optimizing their credit score to prepare for qualifying or renewing a mortgage, compared with 11 per cent nationally.
  • 19 per cent of those surveyed indicated that they are building their credit standing to strengthen rental agreement applications, nearly double the national figure of 10 per cent.
  • 21 per cent of those surveyed know how to improve their credit score but say their financial circumstances prevent them from doing so, compared with 17 per cent nationally.

“Financial literacy is all about understanding the positive steps you can take to strengthen your financial position,” added Oakes. “Regularly reviewing your credit report, making payments on time where possible and understanding how credit utilization affects your score can help consumers make more informed decisions, even when household budgets are tight. Many Canadians are gaining valuable insight into credit building, and consistent actions like monitoring credit reports, paying bills on time, and managing credit utilization can build a solid foundation for achieving lifelong financial goals.”

Equifax Canada encourages consumers to regularly review their credit reports, monitor their credit activity and understand the factors that influence their credit scores. Canadians can access their Equifax credit report and credit score for free through Equifax Canada. Another option for Canadians to consider is subscribing to a credit monitoring and ID protection tool, such as Equifax Complete Protection.

* The Equifax Canada Cybersecurity and Financial Literacy Omnibus survey was conducted by Leger among 1,525 Canadian adults aged 18 and older between October 9 and 11, 2026, with a margin of error of ±2.5 percentage points, 19 times out of 20.

About Equifax
At Equifax, we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.ca.

Contact:

Andrew Findlater
SELECT Public Relations
afindlater@selectpr.ca
(647) 444-1197

Angie Andich
Equifax Canada Media Relations
MediaRelationsCanada@equifax.com

This news release constitutes a “Designated News Release” incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis’ short form base shelf prospectus dated December 9, 2024.

ST. JOHN’S, Newfoundland and Labrador, Nov. 03, 2026 (GLOBE NEWSWIRE) — Fortis Inc. (“Fortis” or the “Corporation”) (TSX/NYSE: FTS), a diversified leader in the North American regulated electric and gas utility industry, released its third quarter results and 2027-2031 outlook.1

Highlights

  • Third quarter net earnings of $474 million or $0.92 per common share, up from $0.81 per common share in 2025
  • Adjusted net earnings per common share2 of $0.92, up from $0.87 per common share in the third quarter of 2025
  • Capital expenditures2 of $4.2 billion through September; capital investment of $6.0 billion expected for 2026
  • Released 2027-2031 capital plan of $32.2 billion, $3.4 billion higher than prior plan and supporting 7.5% rate base growth3
  • Competitive project in Iowa totalling US$1.0 billion awarded to ITC, with US$0.5 billion reflected in the new five-year plan
  • Environmental approval received for both the Tilbury LNG Storage Tank and Phase 2 LNG Expansion projects in British Columbia
  • Recommended Opinion and Order issued with respect to TEP’s rate application
  • Increased fourth quarter common share dividend by 4% and extended annual dividend growth guidance of 4-6% through 2031

“During the third quarter, our utilities executed key capital investments while advancing strategic growth initiatives across our portfolio, including a competitive transmission project at ITC and the Tilbury 1B and Phase 2 LNG expansion projects at FortisBC,” said David Hutchens, President and Chief Executive Officer, Fortis. “Today, we are introducing our new $32.2 billion five-year capital plan, the largest in Fortis history, which reflects the critical investments required to deliver safe, reliable and resilient energy service to our customers. With a strong pipeline of regulated investment opportunities and a proven track record of execution, we are well positioned to deliver sustained rate base growth and 4-6% annual dividend growth through 2031.”

Net Earnings
The Corporation reported net earnings attributable to common equity shareholders (“Net Earnings”) of $474 million for the third quarter of 2026, or $0.92 per common share, an increase of $65 million, or $0.11 per common share compared to the third quarter of 2025. The disposition of FortisTCI in September 2025 resulted in the recognition of income taxes and closing costs of $32 million, or $0.06 per common share, in the third quarter of 2025. Excluding this impact, Net Earnings increased by $33 million quarter-over-quarter primarily due to rate base growth across our utilities. The increase was also due to higher earnings at UNS Energy, reflecting growth in retail electricity sales and the timing of operating costs, partially offset by costs associated with rate base growth not yet reflected in customer rates. The 2025 dispositions of FortisTCI and Fortis Belize and higher holding company finance costs also unfavourably impacted earnings growth for the quarter.

On a year-to-date basis, excluding the impact of income taxes and closing costs related to the 2025 disposition of FortisTCI discussed above, Net Earnings increased by $47 million, or $0.06 per common share. The increase was primarily driven by rate base growth across our utilities, as well as the timing of costs at Central Hudson. These impacts were partially offset by lower earnings at UNS Energy due to lower margin on wholesale sales and costs associated with rate base growth not yet reflected in customer rates, partially offset by higher retail electricity sales. The dispositions of FortisTCI and Fortis Belize in 2025, higher holding company finance costs, and a lower foreign exchange rate also moderated year-to-date earnings growth.

The change in earnings per common share for both the third quarter and year-to-date periods also reflected an increase in the weighted average number of common shares outstanding associated with the Corporation’s dividend reinvestment and at-the-market (“ATM”) equity plans.

On an adjusted earnings per common share basis, the 2025 dispositions had a $0.02 and $0.05 dilutive impact on third quarter and year-to-date results, respectively.

     
1 Financial information is presented in Canadian dollars unless otherwise specified.
2 Fortis uses financial measures that do not have a standardized meaning under generally accepted accounting principles in the United States of America (“U.S. GAAP”) and may not be comparable to similar measures presented by other entities. Fortis presents these non-U.S. GAAP measures because management and external stakeholders use them in evaluating the Corporation’s financial performance. Refer to the Non-U.S. GAAP Reconciliation provided herein.
3 Reflects the five-year compound annual growth rate calculated using a constant U.S. dollar-to-Canadian dollar exchange rate.
     

Adjusted Net Earnings2
Adjusted net earnings attributable to common equity shareholders (“Adjusted Net Earnings”) reflects the removal of items that management excludes in its key decision-making processes and evaluation of operating results. There were no adjustments to Net Earnings for the three and nine months ended September 30, 2026. For the three and nine months ended September 30, 2025, Net Earnings were favourably adjusted by $32 million related to the disposition of FortisTCI, as previously discussed.

2026 Capital Expenditures and New Five-Year Capital Plan
Capital expenditures for 2026 are expected to be approximately $6.0 billion, up from $5.6 billion previously anticipated for the year. The increase is largely driven by the acceleration of major capital projects, including tranche 1 Midcontinent Independent System Operator (“MISO”) long-range transmission plan (“LRTP”) investments at ITC, and the Tilbury Phase 1B project at FortisBC Energy.

The Corporation’s new 2027-2031 capital plan totals $32.2 billion, $3.4 billion higher than the previous five-year plan. The increase is primarily driven by FERC-regulated transmission investments at ITC related to the MISO LRTP tranche 2.1 portfolio of projects, including a competitive project in Iowa awarded to ITC in October 2026, as well as ongoing investment in system reliability and interconnections. The increase also reflects continued development of the Tilbury site, including the Phase 1B expansion and the Liquefied Natural Gas (“LNG”) Storage Tank projects at FortisBC Energy, as well as customer growth and reliability-related investments across the Corporation’s utilities. The plan is low-risk and highly executable.

The five-year capital plan is expected to be funded primarily by cash from operations and regulated utility debt. Common equity is expected to be predominantly supported by the Corporation’s dividend reinvestment plan. The Corporation advanced a portion of its equity funding requirements through the issuance of US$1.0 billion of junior subordinated notes and approximately $260 million of common shares through the ATM equity program in the third quarter of 2026. The Corporation intends to file a new short-form base shelf prospectus and re-establish the ATM equity program in early 2027 to provide funding flexibility.

Significant opportunities remain beyond the five-year plan, including incremental investments associated with MISO LRTP tranche 2.1 projects. ITC estimates a range of US$2.9 billion to US$3.4 billion in capital expenditures beyond the new five-year capital plan for MISO tranche 2.1 projects located in Michigan and Minnesota, where rights of first refusal are in effect, and for projects requiring system upgrades in Iowa which are not subject to a competitive bidding process. In addition, a competitive project in Iowa of US$1.0 billion was recently awarded to ITC, of which US$0.5 billion is included in the five-year plan.

In September 2026, FortisBC Energy received an Environmental Assessment Certificate from the Province of British Columbia and the Government of Canada for the Tilbury Phase 2 LNG Expansion which would provide up to 2.5 million tonnes per annum to serve emerging LNG markets, including marine fuelling. No capital has been included in our new five-year plan associated with the Phase 2 liquefaction expansion project, but investment opportunity of $2 billion to $4 billion exists, depending on market use and a final investment decision. The majority of this investment is expected beyond 2031.

UNS Energy is experiencing strong interest from new and existing customers associated with economic development activity, including opportunities related to data centers, mining, industrial development, electrification, and broader commercial and residential growth. These opportunities could drive additional investment in generation, transmission, and distribution infrastructure over time. Tucson Electric Power (“TEP”) and UNS Electric filed new Integrated Resource Plans (“IRPs”) in October 2026 that support customers’ projected energy needs over the next 15 years while maintaining reliability and affordability. The base case IRPs reflect opportunity above the five-year plan of up to US$1.6 billion through 2031, subject to request for proposal processes. To evaluate the potential growth above the base case IRP, TEP included a high-load factor scenario in its IRP that assumes approximately 800 MW of additional generation and could require up to US$1.5 billion of incremental investment. These opportunities are not currently reflected in the Corporation’s five-year capital plan but represent meaningful long-term growth potential for the business.

Regulatory Update
In October 2026, an Arizona Corporation Commission (“ACC”) Administrative Law Judge issued a Recommended Opinion and Order with respect to TEP’s general rate application, recommending an allowed rate of return on common equity of 9.65% and a 55.5% common equity component of capital structure. The order also included an annual formulaic rate adjustment mechanism with a range of +/‑ 50 basis points around the allowed ROE, the inclusion of post-test year adjustments, and the deferral of certain costs associated with owning and operating the Roadrunner Reserve II battery storage project for future recovery. The Recommended Opinion and Order proposes implementation of new rates by December 1, 2026. The rate application remains subject to ACC approval which is anticipated later this month.

Fourth Quarter 2026 Dividends
The Board of Directors of Fortis has declared the following dividends payable on December 1, 2026 to the Shareholders of Record of the following Shares of the Corporation at the close of business on November 17, 2026:

  • $0.3063 per share on the First Preference Shares, Series “F”;
  • $0.3826875 per share on the First Preference Shares, Series “G”;
  • $0.26144 per share on the First Preference Shares, Series “H”;
  • $0.23311 per share on the First Preference Shares, Series “I”;
  • $0.2969 per share on the First Preference Shares, Series “J”;
  • $0.3418125 per share on the First Preference Shares, Series “K”;
  • $0.3433125 per share on the First Preference Shares, Series “M”; and,
  • $0.665 per share on the Common Shares.

The Corporation has designated the common share dividend and preference share dividends as eligible dividends for federal and provincial dividend tax credit purposes.

Outlook
Fortis continues to enhance shareholder value through the execution of its capital plan, the balance and strength of its diversified portfolio of regulated utility businesses, and growth opportunities within and proximate to its service territories. The Corporation’s $32.2 billion five-year capital plan is expected to increase midyear rate base from $45.3 billion in 2026 to $55.8 billion by 2029 and $63.9 billion by 2031, translating into three- and five-year compound annual growth rates of 7.7% and 7.5%, respectively. Fortis expects its long-term growth in rate base will drive earnings that support dividend growth guidance of 4-6% annually through 2031.

Above and beyond the five-year capital plan, growth opportunities include: further expansion of the electric transmission grid in the U.S. to support load growth and facilitate the interconnection of new energy resources, including transmission investments associated with the MISO LRTP and MISO transmission expansion plan; grid resiliency and climate adaptation investments; investments in renewable gas and LNG infrastructure in British Columbia; and energy infrastructure investments to support the acceleration of load growth across our jurisdictions.

Non-U.S. GAAP Reconciliation                      
Periods ended September 30 Quarter   Year-to-Date
($ millions) 2026     2025     Variance   2026     2025     Variance
Adjusted Net Earnings                      
Net Earnings 474     409     65     1,371     1,292     79  
Adjusting item:                      
Disposition of FortisTCI4 —     32     (32 )   —     32     (32 )
Adjusted Net Earnings 474     441     33     1,371     1,324     47  
Adjusted net earnings per share ($) 0.92     0.87     0.05     2.69     2.63     0.06  
                       
Capital Expenditures                      
Additions to property, plant and equipment 1,758     1,362     396     4,862     4,324     538  
Additions to intangible assets 35     91     (56 )   143     216     (73 )
Adjusting item:                      
Eagle Mountain Pipeline Project5 (301 )   (137 )   (164 )   (787 )   (369 )   (418 )
Capital Expenditures 1,492     1,316     176     4,218     4,171     47  
                                   

About Fortis
Fortis is a diversified leader in the North American regulated electric and gas utility industry with 2025 revenue of $12 billion and total assets of $82 billion as at September 30, 2026. The Corporation’s 9,900 employees serve utility customers in five Canadian provinces, ten U.S. states and the Cayman Islands.

     
4 Reflects income taxes and closing costs associated with the disposition of FortisTCI.
5 Represents contributions in aid of construction received for the Eagle Mountain Pipeline project.
     

Forward-Looking Information
Fortis includes forward-looking information in this media release within the meaning of applicable Canadian securities laws and forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 (collectively referred to as “forward-looking information”). Forward-looking information reflects expectations of Fortis management regarding future growth, results of operations, performance, business prospects, and opportunities. Wherever possible, words such as anticipates, believes, budgets, could, estimates, expects, forecasts, intends, may, might, plans, projects, schedule, should, target, will, would, and the negative of these terms, and other similar terminology or expressions, have been used to identify the forward-looking information, which includes, without limitation: forecast capital expenditures for 2026 and 2027-2031; forecast midyear rate base for 2026, 2029 and 2031, and forecast three- and five-year compound annual growth rates; annual dividend growth guidance through 2031; expected nature, timing, benefits and costs of certain major capital projects, including investments at ITC related to MISO LRTP tranche 2.1 projects and ongoing investment in system reliability and interconnections, continued development of the Tilbury 1B and Tilbury LNG Storage Tank Expansion projects at FortisBC Energy, and customer growth and reliability-related investments across the Corporation’s utilities; expected sources of funding for the five-year capital plan, including the source of common equity proceeds; the Corporation’s intention to re-establish its ATM Program in early 2027; expected nature, timing, benefits, and costs of additional investment opportunities, including further investments by ITC associated with MISO LRTP tranche 2.1 projects, investments at FortisBC Energy associated with the Tilbury Phase 2 LNG Expansion, investments at UNS Energy associated with additional energy demands, and investments associated with IRPs filed by TEP and UNS Electric; the Corporation’s goal of achieving net zero direct greenhouse gas emissions by 2050; expected timing, outcome and impact of legal and regulatory proceedings and decisions; the expectation that long-term growth in rate base will drive earnings that support dividend growth guidance; and the expected nature, timing and benefits of growth opportunities above and beyond the five-year capital plan, including further expansion of the electric transmission grid in the U.S. to support load growth and facilitate the interconnection of new energy resources, including transmission investments associated with the MISO LRTP and MISO transmission expansion plan, grid resiliency and climate adaptation investments, investments in renewable gas and LNG infrastructure in British Columbia, and energy infrastructure investments to support the acceleration of load growth.

Forward-looking information involves significant risks, uncertainties, and assumptions. Certain material factors or assumptions have been applied in drawing the conclusions contained in the forward-looking information, including, without limitation: the successful execution of the capital plan; no material capital project and financing cost overrun; sufficient human resources to deliver service and execute the capital plan; the realization of additional opportunities beyond the capital plan; no significant variability in interest rates; no material changes in the assumed U.S. dollar-to-Canadian dollar exchange rate; the continuation of current participation levels in the Corporation’s dividend reinvestment plan; reasonable outcomes for legal and regulatory proceedings and the expectation of regulatory stability; and the Board of Directors of the Corporation exercising its discretion to declare dividends, taking into account the business performance and financial condition of the Corporation. Fortis cautions readers that a number of factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking information. For additional information with respect to certain risk factors, reference should be made to the continuous disclosure materials filed from time to time by the Corporation with Canadian securities regulatory authorities and the Securities and Exchange Commission. All forward-looking information herein is given as of the date of this media release. Fortis disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

Teleconference and Webcast
A teleconference and webcast will be held on November 3, 2026 at 8:30 a.m. (Eastern) during which David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Corporation’s third quarter financial results and new five-year outlook.

Shareholders, analysts, members of the media and other interested parties are invited to listen to the teleconference via the live webcast on the Corporation’s website, www.fortisinc.com/investors/events-and-presentations.

Those members of the financial community in Canada and the United States wishing to ask questions during the call are invited to participate toll free by calling 1.833.821.0229. Individuals in other international locations can participate by calling 1.647.846.2371. Please dial in 10 minutes prior to the start of the call. No access code is required.

An archived audio webcast of the teleconference will be available on the Corporation’s website two hours after the conclusion of the call until December 3, 2026. Please call 1.855.669.9658 or 1.412.317.0088 and enter access code 6446629#.

Additional Information
This news release should be read in conjunction with the Corporation’s September 30, 2026 Interim Management Discussion and Analysis and Condensed Consolidated Financial Statements. This and additional information can be accessed at www.fortisinc.com, www.sedarplus.ca, or www.sec.gov.

A .pdf version of this press release is available at: http://ml.globenewswire.com/Resource/Download/38eeb56e-2e0e-4158-b3ca-0daa442717e8

For more information, please contact:

Investor Enquiries Media Enquiries
Ms. Stephanie Amaimo Ms. Karen McCarthy
Vice President, Investor Relations Vice President, Communications & Government Relations
Fortis Inc. Fortis Inc.
248.946.3572 709.737.5323
investorrelations@fortisinc.com media@fortisinc.com

Rising Dragon to continue to pursue an initial business combination

Taiyuan, China, Nov. 03, 2026 (GLOBE NEWSWIRE) — Rising Dragon Acquisition Corp. (Nasdaq: RDAC, RDACU, RDACR) (“Rising Dragon” or the “Company”), a special purpose acquisition company, today announced that it and HZJL Cayman Limited (“HZJL”) have mutually agreed, effective as of October 30, 2026, to terminate the Agreement and Plan of Merger, dated January 27, 2025 (the “Merger Agreement”), by and among the Company, Xpand Boom Technology Inc., Xpand Boom Solutions Inc., HZJL, XB B Limited and Bin Xiong.

The termination was approved by the boards of directors of Rising Dragon and HZJL. Under the terms of the termination agreement dated October 30, 2026 (the “Termination Agreement”), no party is required to pay a termination fee to any other party, and the parties have agreed to mutually release each other from claims relating to the Merger Agreement and the transactions contemplated thereby, subject to certain exceptions.

Rising Dragon intends to continue to pursue the consummation of an initial business combination with an appropriate target business within the time period permitted under its amended and restated memorandum and articles of association.

Additional information regarding the termination of the Merger Agreement is included in a Current Report on Form 8-K to be filed by Rising Dragon with the U.S. Securities and Exchange Commission (the “SEC”).

About Rising Dragon Acquisition Corp.

Rising Dragon Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company completed its initial public offering pursuant to a prospectus dated October 10, 2024.

Forward-Looking Statements

This press release contains certain “forward-looking statements” within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, including statements regarding Rising Dragon’s intention to pursue an initial business combination. The words “expect,” “believe,” “estimate,” “intend,” “plan” and similar expressions indicate forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to various risks and uncertainties, including Rising Dragon’s ability to identify a suitable target and complete an initial business combination within the time required by its governing documents, and the other risks and uncertainties described in Rising Dragon’s filings with the SEC, including its initial public offering prospectus dated October 10, 2024, its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Should one or more of these risks or uncertainties materialize, actual results may vary materially from those indicated or anticipated. Forward-looking statements speak only as of the date they are made, and Rising Dragon undertakes no obligation to update them except as required by law.

Contact

Rising Dragon Acquisition Corp.
Woody Shen, Chief Financial Officer
No. 604, Yixing Road, Wanbolin District, Taiyuan City, Shanxi Province, People’s Republic of China 030024
Tel: +86 18817777987
Email: woody.shen@hywincapital.cn

– Q3 2026 Net Revenue of $863 million; GAAP Net Loss of $22 million; Diluted Loss per Share of $(0.06) –
– Adjusted EBITDA of $207 million; Adjusted Diluted EPS of $0.26 –
– Updating 2026 Full Year Guidance –

BRIDGEWATER, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced its results for the third quarter ended September 30, 2026.

“Amneal delivered another quarter of strong, broad-based performance, enabling us to increase our 2026 guidance once more. As we prepare to enter 2027, our financial performance is accelerating driven by a number of key catalysts and new launches, including Women’s Health patches, biosimilars, injectables such as lanreotide, CREXONT®, and BREKIYA® autoinjector. The Kashiv integration is proceeding well, and we are excited about the long-term growth potential in biosimilars. With the breadth and depth of opportunities across our portfolio, we remain highly confident in Amneal’s robust growth outlook,” said Chirag and Chintu Patel, Co-Founders and Co-Chief Executive Officers of Amneal.

Third Quarter 2026 Results
Net revenue in the third quarter of 2026 was $863 million, an increase of 10% compared to $785 million in the third quarter of 2025. Affordable Medicines net revenue increased 19%, driven by biosimilars, women’s health patches, and new launches. Specialty net revenue increased 20%, driven by key branded products, including CREXONT®, BREKIYA® autoinjector, and UNITHROID®. AvKARE net revenue decreased 17%, as expected, due to a non-recurring cardiovascular product launch in the prior year.

Net loss attributable to Amneal Pharmaceuticals, Inc. was $22 million in the third quarter of 2026 compared to net income of $2 million in the third quarter of 2025 as higher revenue and gross profit were more than offset by non-recurring acquisition and integration costs, and higher tax provision.

Adjusted EBITDA in the third quarter of 2026 was $207 million, an increase of 30% compared to the third quarter of 2025, reflecting higher revenue, higher gross profit, and lower operating expenses.

Diluted loss per share in the third quarter of 2026 was $(0.06) compared to diluted income per share of $0.01 for the third quarter of 2025, due to the aforementioned factors and higher share count as a result of the Kashiv acquisition. Adjusted diluted earnings per share in the third quarter of 2026 was $0.26, an increase of 53% compared to $0.17 for the third quarter of 2025.

The Company presents GAAP and adjusted (non-GAAP) quarterly results. Please refer to the “Non-GAAP Financial Measures” section and the accompanying GAAP to non-GAAP reconciliation tables for more information.

Updating 2026 Full Year Guidance
We are increasing full year 2026 guidance for net revenue, adjusted EBITDA, and adjusted diluted EPS. The Company is also updating operating cash flow guidance, reflecting working capital, including higher inventory levels in key growth areas.

  Updated Guidance Prior Guidance
Net revenue $3.15 billion – $3.25 billion $3.10 billion – $3.20 billion
Adjusted EBITDA (1) $800 million – $815 million $750 million – $780 million
Adjusted diluted EPS (2) $1.04 – $1.08 $0.96 – $1.06
Operating cash flow (3) $325 million – $375 million $350 million – $400 million
Operating cash flow, excluding discrete items (4) $350 million – $400 million $375 million – $425 million
Capital expenditures (5) ~$150 million ~$150 million

(1) Includes 100% of adjusted EBITDA from AvKARE. See also “Non-GAAP Financial Measures” below.
(2) Accounts for non-controlling interest in AvKARE. Assumes approximately 340 million weighted-average diluted shares outstanding for the year ending December 31, 2026.
(3) Represents cash provided by operating activities.
(4) Excludes discrete items such as opioid settlement costs of approximately $36 million and Kashiv acquisition and integration costs of approximately $40 million.
(5) Reflects estimated capital expenditures and deposits for future acquisition of property, plant, and equipment.
   

Amneal’s 2026 estimates are based on management’s current expectations, including with respect to prescription trends, pricing levels, the timing of future product launches, the costs incurred and benefits realized of restructuring activities, and our long-term strategy. The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The Company cannot provide a reconciliation between non-GAAP projections and the most directly comparable measures in accordance with GAAP without unreasonable efforts because it is unable to predict with reasonable certainty the ultimate outcome of certain significant items required for the reconciliation. The items include, but are not limited to, acquisition-related expenses, restructuring expenses and benefits, asset impairments, legal settlements, and other gains and losses. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results.

Conference Call Information
Amneal will host a conference call and live webcast at 8:30 am Eastern Time today, November 3, 2026, to discuss its results. The live webcast and presentation will be accessible through the Investor Relations section of the Company’s website at https://investors.amneal.com. To access the call through a conference line, dial 1 (833) 461-5787 (in the U.S.) with access code 304152835. A replay of the conference call will be posted shortly after the call. For a list of toll-free international numbers, visit this website: https://help.events.q4inc.com/eahc/international-dial-in-numbers.

About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, New Jersey, is a diversified, global biopharmaceutical leader focused on expanding access to affordable and innovative medicines. Amneal was founded in 2002 by brothers and co-CEOs Chirag and Chintu Patel, and built on the belief that innovation only matters if it’s accessible. Today, Amneal has a diverse and growing portfolio of approximately 300 complex generic, specialty and biosimilar medicines, delivering more than 160 million prescriptions annually, primarily in the United States. Our Affordable Medicines segment spans retail generics, injectables, and biosimilars. Our Specialty segment provides branded treatments in neurology, including Parkinson’s disease and migraine, and endocrinology. Our AvKARE segment distributes pharmaceuticals and medical products to U.S. federal, retail, and institutional customers. For additional information, please visit amneal.com and follow us on LinkedIn.

Cautionary Statement on Forward-Looking Statements
Certain statements contained herein, regarding matters that are not historical facts, may be forward-looking statements (as defined in the U.S. Private Securities Litigation Reform Act of 1995). Such forward-looking statements include statements regarding management’s intentions, plans, beliefs, expectations, financial results, or forecasts for the future, including among other things: discussions of future operations; expected or estimated operating results and financial performance; statements regarding product launches; statements regarding our potential growth and other non-historical statements. Words such as “plans,” “expects,” “will,” “anticipates,” “estimates,” and similar words, or the negatives thereof, are intended to identify estimates and forward-looking statements.

The reader is cautioned not to rely on these forward-looking statements. These forward-looking statements are based on current expectations of future events, including with respect to future market conditions, company performance and financial results, operational investments, business prospects, new strategies and growth initiatives, the competitive environment, and other events. If the underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of the Company.

Such risks and uncertainties include, but are not limited to: risks related to integrating our acquisition (the “Kashiv Acquisition”) of Kashiv BioSciences, LLC (“Kashiv”) and realizing the anticipated benefits of the acquisition; our ability to successfully develop, license, acquire and commercialize new products on a timely basis; the competition we face in the pharmaceutical industry from brand and generic drug product companies, and the impact of that competition on our ability to set prices; our ability to obtain exclusive marketing rights for our products; the impact of illegal distribution and sale by third parties of counterfeit versions of our products or stolen products; the impact of negative market perceptions of us and the safety and quality of our products; our revenues are derived from the sales of a limited number of products, a substantial portion of which are through a limited number of customers; the continuing trend of consolidation of certain customer groups; the impact of supply chain disruption; the imposition of tariffs may adversely affect our business, results of operations and financial condition; a U.S. government shutdown could adversely impact our regulatory, operational and financial performance; legal, regulatory and legislative efforts by our brand competitors to deter competition from our generic alternatives; our dependence on information technology systems and infrastructure and the potential for cybersecurity incidents, and risks associated with artificial intelligence; the impact of a prolonged business interruption within our supply chain; our ability to attract, hire and retain highly skilled personnel; risks related to federal regulation of arrangements between manufacturers of branded and generic products; our reliance on certain licenses to proprietary technologies from time to time; the significant amount of resources we expend on research and development; the risk of claims brought against us by third parties; risks related to changes in the regulatory environment, including U.S. federal and state laws related to government contracting, healthcare fraud abuse and health information privacy and security and changes in such laws; changes to Food and Drug Administration product approval requirements and review processes; the impact of healthcare reform and changes in coverage and reimbursement levels and funding by governmental authorities and other third-party payers; our ability to identify, make and integrate acquisitions or investments in complementary businesses and products on advantageous terms; our dependence on third-party agreements for a portion of our product offerings; our potential expansion into additional international markets subjecting us to increased regulatory, economic, social and political uncertainties; the impact of global economic, political or other catastrophic events; our substantial amount of indebtedness and our ability to generate sufficient cash to service our indebtedness in the future, and the impact of interest rate fluctuations on such indebtedness; our obligations under a tax receivable agreement may be significant; and the high concentration of ownership of our Class A common stock by the Amneal Group. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company’s filings with the Securities and Exchange Commission, including under Item 1A, “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and in its subsequent reports on Forms 10-Q and 8-K. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. Forward-looking statements included herein speak only as of the date hereof and we undertake no obligation to revise or update such statements to reflect the occurrence of events or circumstances after the date hereof.

Non-GAAP Financial Measures
This release includes certain non-GAAP financial measures, including EBITDA, adjusted EBITDA, adjusted net income, adjusted diluted EPS, adjusted gross margin, adjusted operating income, net debt, gross leverage, and net leverage, which are intended as supplemental measures of the Company’s performance that are not required by or presented in accordance with GAAP.

Management uses these non-GAAP measures internally to evaluate and manage the Company’s operations and to better understand its business because they facilitate a comparative assessment of the Company’s operating performance relative to its performance based on results calculated under GAAP. These non-GAAP measures also isolate the effects of some items that vary from period to period without any correlation to core operating performance and eliminate certain charges that management believes do not reflect the Company’s operations and underlying operational performance. The compensation committee of the Company’s board of directors also uses certain of these measures to evaluate management’s performance and set its compensation. The Company believes that these non-GAAP measures also provide useful information to investors regarding certain financial and business trends relating to the Company’s financial condition and operating results and facilitate an evaluation of the financial performance of the Company and its operations on a consistent basis. Providing this information therefore allows investors to make independent assessments of the Company’s financial performance, results of operations, cash flows, net leverage and trends while viewing the information through the eyes of management.

These non-GAAP measures are subject to limitations. The non-GAAP measures presented in this release may not be comparable to similarly titled measures used by other companies because other companies may not calculate one or more in the same manner. Additionally, the non-GAAP performance measures exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements; do not reflect changes in, or cash requirements for, working capital needs; and do not reflect interest expense, or the requirements necessary to service interest or principal payments on debt. Further, our historical adjusted results are not intended to project our adjusted results of operations or financial position for any future period. To compensate for these limitations, management presents and considers these non-GAAP measures in conjunction with the Company’s GAAP results; no non-GAAP measure should be considered in isolation from or as an alternative to any measure determined in accordance with GAAP. Readers should review the reconciliations included below, and should not rely on any single financial measure to evaluate the Company’s business.

A reconciliation of each historical non-GAAP measure to the most directly comparable GAAP measure is set forth below.

Contact
Anthony DiMeo
VP, Investor Relations
anthony.dimeo@amneal.com

Amneal Pharmaceuticals, Inc.
Consolidated Statements of Operations
(unaudited; in thousands, except per share amounts)

    Three Months Ended
September 30,
  Nine Months Ended
September 30,
      2026       2025       2026       2025  
Net revenue   $ 862,684     $ 784,513     $ 2,381,400     $ 2,204,441  
Cost of goods sold     528,566       510,539       1,392,661       1,388,323  
Gross profit     334,118       273,974       988,739       816,118  
Selling, general and administrative     139,645       137,815       427,227       380,369  
Research and development     68,374       63,352       145,774       151,356  
Intellectual property legal development expenses     2,193       2,437       5,822       6,221  
Acquisition and integration costs     22,320       —       35,073       —  
Restructuring and other charges     936       143       2,140       1,738  
Change in fair value of contingent consideration     (6,000 )     —       (6,000 )     —  
Charges for property losses and associated expenses     5,369       —       5,369       —  
Charges (credit) related to legal matters, net     6,497       —       15,248       (390 )
Other operating income     (631 )     (117 )     (8,870 )     (5,239 )
Operating income     95,415       70,344       366,956       282,063  
Other (expense) income:                
Interest expense, net     (58,913 )     (62,814 )     (167,317 )     (184,854 )
Foreign exchange (loss) gain, net     (3,174 )     (3,431 )     (12,924 )     9,072  
Loss on refinancing     (5,760 )     (31,365 )     (9,270 )     (31,365 )
(Increase) decrease in tax receivable agreement liability     (12,992 )     20,808       (13,098 )     5,701  
Other income, net     481       1,235       1,876       3,357  
Total other expense, net     (80,358 )     (75,567 )     (200,733 )     (198,089 )
Income (loss) before income taxes     15,057       (5,223 )     166,223       83,974  
Provision for (benefit from) income taxes     2,751       (23,355 )     6,303       5,614  
Net income     12,306       18,132       159,920       78,360  
Less: Net income attributable to non-controlling interests     (19,762 )     (15,763 )     (47,458 )     (41,379 )
Net (loss) income attributable to Amneal Pharmaceuticals, Inc. before accretion of redeemable non-controlling interests     (7,456 )     2,369       112,462       36,981  
Accretion of redeemable non-controlling interests     (14,239 )     —       (14,239 )     —  
Net (loss) income attributable to Amneal Pharmaceuticals, Inc.   $ (21,695 )   $ 2,369     $ 98,223     $ 36,981  
                 
Net income per share attributable to Amneal Pharmaceuticals, Inc.’s Class A common stockholders:                
Basic   $ (0.06 )   $ 0.01     $ 0.30     $ 0.12  
Diluted   $ (0.06 )   $ 0.01     $ 0.29     $ 0.11  
Weighted-average common shares outstanding:                
Basic     335,733       314,168       323,724       312,998  
Diluted     335,733       324,754       335,233       323,704  

Amneal Pharmaceuticals, Inc.
Condensed Consolidated Balance Sheets
(unaudited; in thousands)

    September 30, 2026
  December 31, 2025
Assets          
Current assets:          
Cash and cash equivalents   $ 157,399     $ 282,029  
Restricted cash     14,174       28,842  
Trade accounts receivable, net     1,016,844       895,143  
Inventories     707,956       606,302  
Prepaid expenses and other current assets     196,769       98,395  
Related party receivables     1,876       470  
Total current assets     2,095,018       1,911,181  
Property, plant and equipment, net     572,634       442,950  
Goodwill and intangible assets, net     2,323,728       1,158,968  
Operating lease right-of-use assets     69,760       38,832  
Operating lease right-of-use assets – related party     20,019       15,216  
Financing lease right-of-use assets     63,255       53,328  
Other assets     122,807       57,805  
Total assets   $ 5,267,221     $ 3,678,280  
Liabilities and Stockholders’ Equity (Deficiency)          
Current liabilities:          
Accounts payable and accrued expenses   $ 788,831     $ 761,316  
Current portion of liabilities for legal matters     27,534       43,256  
Revolving credit facility     180,000       —  
Current portion of long-term debt, net     23,933       6,761  
Current portion of operating lease liabilities     14,417       8,668  
Current portion of operating lease liabilities – related party     3,398       2,705  
Current portion of financing lease liabilities     3,811       3,442  
Related party payables – short term     18,913       55,485  
Contingent consideration – related party – short term     59,000       —  
Total current liabilities     1,119,837       881,633  
Long-term debt, net     2,915,501       2,565,115  
Operating lease liabilities     59,612       33,233  
Operating lease liabilities – related party     16,635       14,195  
Financing lease liabilities     65,588       54,927  
Related party payables – long term     15,878       19,132  
Liabilities for legal matters – long term     71,663       71,819  
Contingent consideration – related party – long term     324,000       —  
Other long-term liabilities     37,797       32,263  
Total long-term liabilities     3,506,674       2,790,684  
Redeemable non-controlling interests     109,453       77,292  
Total stockholders’ equity (deficiency)     531,257       (71,329 )
Total liabilities and stockholders’ equity (deficiency)   $ 5,267,221     $ 3,678,280  

Amneal Pharmaceuticals, Inc.
Consolidated Statements of Cash Flows
(unaudited; in thousands)

    Nine Months Ended September 30,
      2026       2025  
Cash flows from operating activities:        
Net income   $ 159,920     $ 78,360  
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization     144,250       174,345  
Unrealized foreign currency loss (gain)     13,571       (8,606 )
Amortization of debt issuance costs and discount     12,141       18,716  
Reclassification of cash flow hedge     8,730       (1,713 )
Loss on refinancing     9,270       31,365  
Intangible asset impairment charges     975       22,784  
Research and development equipment impairment charges     13,832       —  
Non-cash property losses     5,035       —  
Change in fair value of contingent consideration     (6,000 )     —  
Stock-based compensation     29,723       23,751  
Inventory provision     64,981       59,326  
Other operating charges and credits, net     4,689       3,575  
Changes in assets and liabilities:        
Trade accounts receivable, net     (122,423 )     (110,228 )
Inventories     (158,346 )     (66,846 )
Prepaid expenses, other current assets and other assets     (113,073 )     (20,173 )
Related party receivables     203       (830 )
Accounts payable, accrued expenses and other liabilities     17,590       2,744  
Related party payables     (34,756 )     3,107  
Net cash provided by operating activities     50,312       209,677  
Cash flows from investing activities:        
Acquisition of Kashiv, net of cash and restricted cash acquired     (421,047 )     —  
Purchases of property, plant and equipment     (70,659 )     (48,290 )
Acquisition of intangible assets     (96,603 )     (12,514 )
Deposits for future acquisition of property, plant and equipment     (28,376 )     (7,384 )
Proceeds from sale of property, plant and equipment     —       1,379  
Net cash used in investing activities     (616,685 )     (66,809 )
Cash flows from financing activities:        
Payments of principal on debt, revolving credit facilities, financing leases and other     (293,172 )     (2,805,384 )
Proceeds from issuance of debt     529,853       2,694,750  
Payments of deferred financing and refinancing costs     (7,549 )     (74,973 )
Borrowings on revolving credit facilities     280,000       218,000  
Proceeds from exercise of stock options     516       1,407  
Employee payroll tax withholding on restricted stock unit and performance stock unit vesting     (44,696 )     (21,957 )
Tax and other distributions to non-controlling interests     (29,571 )     (38,825 )
Proceeds from alliance party     510       5,572  
Acquisition of non-controlling interest     (400 )     —  
Net cash provided by (used in) financing activities     435,491       (21,410 )
Effect of foreign exchange rate on cash     (1,804 )     (1,471 )
Net decrease in cash, cash equivalents, and restricted cash     (132,686 )     119,987  
Cash, cash equivalents, and restricted cash – beginning of period     312,939       118,420  
Cash, cash equivalents, and restricted cash – end of period   $ 180,253     $ 238,407  
Cash and cash equivalents – end of period   $ 157,399     $ 201,249  
Restricted cash – end of period     14,174       34,727  
Long-term restricted cash included in other assets – end of period     8,680       2,431  
Cash, cash equivalents, and restricted cash – end of period   $ 180,253     $ 238,407  

Amneal Pharmaceuticals, Inc.
Non-GAAP Reconciliations
(unaudited, in thousands)

Reconciliation of Net Income to EBITDA and Adjusted EBITDA

    Three Months Ended
September 30,
  Nine Months Ended
September 30,
  Year Ended
December 31,
      2026       2025       2026       2025       2025  
Net income   $ 12,306     $ 18,132     $ 159,920     $ 78,360     $ 127,933  
Adjusted to add:                    
Interest expense, net     58,913       62,814       167,317       184,854       241,091  
Provision for (benefit from) income taxes     2,751       (23,355 )     6,303       5,614       11,276  
Depreciation and amortization     53,259       54,073       144,250       174,345       223,572  
EBITDA (Non-GAAP)   $ 127,229     $ 111,664     $ 477,790     $ 443,173     $ 603,872  
Adjusted to add (deduct):                    
Stock-based compensation expense     10,515       8,219       29,723       23,621       31,823  
Acquisition, site closure, and idle facility expenses (1)     22,745       2,318       36,503       4,762       5,301  
Restructuring and other charges     890       143       1,389       1,738       4,208  
Loss on refinancing (2)     5,760       31,365       9,270       31,365       31,365  
Amortization of acquired inventory step-up     946       —       946       —       —  
Charges (credit) related to legal matters, net (3)     7,500       —       16,251       (390 )     (390 )
Asset impairment charges (4)     14,809       22,784       14,809       22,888       23,022  
Foreign exchange loss (gain)     3,174       3,431       12,924       (9,072 )     (7,635 )
Change in fair value of contingent consideration (5)     (6,000 )     —       (6,000 )     —       —  
Charges for property losses and associated expenses (6)     5,369       —       5,369       —       —  
Increase (decrease) in tax receivable agreement liability     12,992       (20,808 )     13,098       (5,701 )     6,588  
Other (7)     1,100       459       3,417       829       (9,739 )
Adjusted EBITDA (Non-GAAP)   $ 207,029     $ 159,575     $ 615,489     $ 513,213     $ 688,415  

Amneal Pharmaceuticals, Inc.
Non-GAAP Reconciliations
(unaudited, $ in thousands)

Calculation of Net Debt and Net Leverage

    September 30, 2026
  December 31, 2025
Term Loan Due 2032   $ 2,434,263     $ 2,094,750  
Senior Notes Due 2032     600,000       600,000  
2025 Revolving Credit Facility     180,000       —  
Kashiv Rupee Term Loan Facility     16,484       —  
Gross debt (8)   $ 3,230,747     $ 2,694,750  
Less: Cash and cash equivalents     157,399       282,029  
Net debt (Non-GAAP) (9)   $ 3,073,348     $ 2,412,721  
             
    Adjusted EBITDA (Non-GAAP)
  Adjusted EBITDA (Non-GAAP)
Year ended December 31, 2025   $ 688,415     $ 688,415  
Less: Nine months ended September 30, 2025     513,213        
Add: Nine months ended September 30, 2026     615,489        
Last twelve months ended September 30, 2026   $ 790,691        
             
    Last Twelve Months Ended
September 30, 2026
  Year Ended December 31, 2025
Gross leverage (Non-GAAP) (10)   4.1 x   3.9 x
             
Net leverage (Non-GAAP) (11)   3.9 x   3.5 x

Amneal Pharmaceuticals, Inc.
Non-GAAP Reconciliations
(unaudited; in thousands, except per share amounts)

Reconciliation of Net Income to Adjusted Net Income and Calculation of Adjusted Diluted Earnings Per Share

    Three Months Ended
September 30,
  Nine Months Ended
September 30,
      2026       2025       2026       2025  
Net income   $ 12,306     $ 18,132     $ 159,920     $ 78,360  
Adjusted to add (deduct):                
Non-cash interest     7,098       9,163       20,779       16,908  
GAAP provision for (benefit from) income taxes     2,751       (23,355 )     6,303       5,614  
Amortization     37,671       38,647       100,696       127,741  
Stock-based compensation expense     10,515       8,219       29,723       23,621  
Acquisition, site closure, and idle facility expenses (1)     22,745       2,284       36,503       4,700  
Restructuring and other charges     890       143       1,389       1,731  
Loss on refinancing (2)     5,760       31,365       9,270       31,365  
Amortization of acquired inventory step-up     946       —       946       —  
Charges (credit) related to legal matters, including interest, net (3)     8,585       —       19,152       (390 )
Asset impairment charges (4)     14,809       22,784       14,809       22,888  
Change in fair value of contingent consideration (5)     (6,000 )     —       (6,000 )     —  
Charges for property losses and associated expenses (6)     5,369       —       5,369       —  
Increase (decrease) in tax receivable agreement liability     12,992       (20,808 )     13,098       (5,701 )
Other     1,100       459       3,417       839  
Provision for income taxes (12)     (28,270 )     (16,868 )     (90,030 )     (65,722 )
Net income attributable to non-controlling interests     (19,762 )     (15,763 )     (47,458 )     (41,379 )
Adjusted net income (Non-GAAP)   $ 89,505     $ 54,402     $ 277,886     $ 200,575  
Weighted-average diluted shares outstanding (13)     348,448       324,754       335,233       323,704  
Diluted (loss) earnings per share (GAAP)   $ (0.06 )   $ 0.01     $ 0.29     $ 0.11  
Adjusted diluted earnings per share (Non-GAAP)   $ 0.26     $ 0.17     $ 0.83     $ 0.62  

Amneal Pharmaceuticals, Inc.
Non-GAAP Reconciliations
(unaudited)

Explanations for Non-GAAP Reconciliations

(1) Acquisition, site closure, and idle facility expenses for the three and nine months ended September 30, 2026 primarily included acquisition costs associated with the acquisition of Kashiv and rent for vacated properties. Acquisition, site closure, and idle facility expenses for the three and nine months ended September 30, 2025 and year ended December 31, 2025 primarily included costs related to a planned facility closure and rent for vacated properties.

(2) Loss on refinancing for the three and nine months ended September 30, 2026 was primarily comprised of debt issuance costs and the write-off of unamortized debt issuance costs. In February 2026, the Company entered into a repricing amendment for the Company’s Term Loan Due 2032 (the “February 2026 Repricing Amendment”), which reduced the applicable interest rate margins on such term loan. In August 2026, the Company entered into another repricing amendment for the Company’s Term Loan Due 2032 (the “August 2026 Repricing Amendment”), which further reduced the applicable interest rate margins on such term loan. Also in August 2026, the Company borrowed an additional $350.0 million under Amendment No. 4 to the Company’s Term Loan Credit Agreement (the “Incremental Term Loans”) to fund a portion of the cash consideration for the Kashiv Acquisition. The loss for the three months ended September 30, 2026 primarily reflects costs associated with the August 2026 Repricing Amendment and the Incremental Term Loans, while the loss for the nine months ended September 30, 2026 primarily reflects costs associated with the February 2026 Repricing Amendment, the August 2026 Repricing Amendment and the Incremental Term Loans. For 2025, loss on refinancing was primarily comprised of debt issuance costs associated with the portion of the Term Loan Due 2028 that was modified as part of the Company’s debt refinancing on August 1, 2025. Refer to Note 14. Debt in the Company’s 2025 Annual Report on Form 10-K for information about the Company’s debt as of December 31, 2025.

(3) For the three months ended September 30, 2026, charges related to legal matters, net were $7.5 million, primarily consisting of a charge related to government investigations of $8.0 million, partially offset by immaterial net credits related to several matters. For the nine months ended September 30, 2026, charges related to legal matters, net were $16.3 million, primarily consisting of (i) a $21.2 million charge associated with certain states electing a 25% cash conversion in lieu of product under the Nationwide Opioids Settlement Agreement, partially offset by a $20.8 million discount recorded on the expected settlement payments as of the agreement’s effective date, (ii) net charges associated with antitrust class action litigation of $7.5 million, (iii) a charge related to government investigations of $8.0 million, and (iv) immaterial net charges related to several matters. For the three and nine months ended September 30, 2026, charges related to legal matters, including interest, net also included interest expense associated with the Nationwide Opioids Settlement Agreement. For additional information regarding the Nationwide Opioids Settlement Agreement and antitrust class action litigation, refer to Note 16. Commitments and Contingencies in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.

(4) For the three and nine months ended September 30, 2026, impairment charges related to certain equipment used in research and development activities as a result of a change in the expected future utilization of the assets as well as an immaterial intangible asset impairment. For 2025, asset impairment charges primarily related to a Specialty segment product right for which the Company significantly reduced the cash flow forecast after receipt of a complete response letter dated July 22, 2025 from the U.S. Food and Drug Administration regarding a supplemental new drug application.

(5) During the three and nine months ended September 30, 2026, the Company recognized a $6.0 million gain related to the remeasurement of contingent consideration associated with the Kashiv Acquisition. The gain reflects the periodic remeasurement of the contingent consideration liability driven primarily by increases in the discount rate subsequent to the acquisition date.

(6) During the third week of July 2026, severe rain caused water damage to one of the Company’s facilities in India. Operations at this facility were temporarily suspended while the Company assessed the damage, completed remediation and repair activities, and restored operations. The Company concluded that certain property and equipment and inventory were damaged. The Company also incurred costs related to cleanup, repair and remediation. Accordingly, the Company recorded charges related to inventory and property losses and associated cleanup, repair and remediation costs.

(7) For the year ended December 31, 2025, the caption “other” primarily reflects a non-recurring, non-operating, non-cash gain.

(8) Refer to Note 14. Debt in the Company’s 2025 Annual Report on Form 10-K for additional information about the Company’s debt. On August 10, 2026, the Company borrowed an additional $350.0 million under its Term Loan Due 2032, with substantially the same terms as the existing term loans, primarily to finance a portion of the cash consideration for the Kashiv Acquisition. Additionally, in connection with the Kashiv Acquisition, the Company assumed the Kashiv Rupee Term Loan Facility. The Company repaid the facility in full and terminated it on October 1, 2026.

(9) Net debt was calculated as the total outstanding principal on the Company’s debt less cash and cash equivalents.

(10) Gross leverage was calculated by dividing gross debt as of September 30, 2026 and December 31, 2025 by adjusted EBITDA for the last twelve months ended September 30, 2026 and year ended December 31, 2025, respectively.

(11) Net leverage was calculated by dividing net debt as of September 30, 2026 and December 31, 2025 by adjusted EBITDA for the last twelve months ended September 30, 2026 and year ended December 31, 2025, respectively.

(12) The non-GAAP effective tax rates for the three and nine months ended September 30, 2026 were 24.0% and 24.5%, respectively. The non-GAAP effective tax rates for the three and nine months ended September 30, 2025 were 23.7% and 24.7%, respectively.

(13) Weighted-average diluted shares outstanding for the three and nine months ended September 30, 2026 and 2025 consisted of fully diluted Class A common stock (inclusive of the effect of dilutive securities).

Amneal Pharmaceuticals, Inc.
Non-GAAP Reconciliations
(unaudited, $ in thousands)

Reconciliation of Consolidated GAAP to Non-GAAP Operating Results

    Three Months Ended September 30, 2026   Three Months Ended September 30, 2025
    As Reported   Adjustments   Non-GAAP   As Reported   Adjustments   Non-GAAP
Net revenue   $ 862,684     $ —     $ 862,684     $ 784,513     $ —     $ 784,513  
Cost of goods sold (1)     528,566       (38,941 )     489,625       510,539       (60,683 )     449,856  
Gross profit     334,118       38,941       373,059       273,974       60,683       334,657  
Gross margin %     38.7 %         43.2 %     34.9 %         42.7 %
                         
Selling, general and administrative (2)     139,645       (13,055 )     126,590       137,815       (11,134 )     126,681  
Research and development (3)     68,374       (14,683 )     53,691       63,352       (2,523 )     60,829  
Intellectual property legal development expenses     2,193       —       2,193       2,437       —       2,437  
Acquisition and integration costs (4)     22,320       (22,320 )     —       —       —       —  
Restructuring and other charges     936       (890 )     46       143       (143 )     —  
Change in fair value of contingent consideration (5)     (6,000 )     6,000       —       —       —       —  
Charges for property losses and associated expenses (6)     5,369       (5,369 )     —       —       —       —  
Charges (credit) related to legal matters, net (7)     6,497       (7,500 )     (1,003 )     —       —       —  
Other operating income     (631 )     —       (631 )     (117 )     —       (117 )
Operating income   $ 95,415     $ 96,758     $ 192,173     $ 70,344     $ 74,483     $ 144,827  

(1) Adjustments for the three months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($1.1 million and $0.9 million), amortization expense ($36.0 million and $36.9 million), amortization of acquired inventory step-up ($0.9 million and none), and asset impairment charges ($1.0 million and $22.8 million).

(2) Adjustments for the three months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($8.6 million and $6.5 million), amortization expense ($2.6 million and $2.7 million), site closure costs ($0.4 million and $0.6 million), and other ($1.4 million and $1.3 million).

(3) Adjustments for the three months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($0.9 million and $0.7 million), asset impairment charges ($13.8 million and none), and site closure costs (none and $1.8 million).

(4) Acquisition and integration costs for the three months ended September 30, 2026 were primarily related to professional services fees (e.g., investment banking, legal, due diligence, financial advisory, accounting, and consulting) associated with the acquisition and integration of Kashiv.

(5) During the three months ended September 30, 2026, the Company recognized a $6.0 million gain related to the remeasurement of contingent consideration associated with the Kashiv Acquisition. The gain reflects the periodic remeasurement of the contingent consideration liability driven primarily by increases in the discount rate subsequent to the acquisition date.

(6) During the third week of July 2026, severe rain caused water damage to one of the Company’s facilities in India. Operations at this facility were temporarily suspended while the Company assessed the damage, completed remediation and repair activities, and restored operations. The Company concluded that certain property and equipment and inventory were damaged. The Company also incurred costs related to cleanup, repair and remediation. Accordingly, the Company recorded charges related to inventory and property losses and associated cleanup, repair and remediation costs.

(7) Adjustments to charges (credit) related to legal matters, net were $7.5 million for the three months ended September 30, 2026, primarily consisting of a charge related to government investigations of $8.0 million, partially offset by immaterial net credits related to several matters.
   

Amneal Pharmaceuticals, Inc.
Non-GAAP Reconciliations
(unaudited, $ in thousands)

Reconciliation of Consolidated GAAP to Non-GAAP Operating Results

    Nine Months Ended September 30, 2026   Nine Months Ended September 30, 2025
    As Reported   Adjustments   Non-GAAP   As Reported   Adjustments   Non-GAAP
Net revenue   $ 2,381,400     $ —     $ 2,381,400     $ 2,204,441     $ —     $ 2,204,441  
Cost of goods sold (1)     1,392,661       (100,569 )     1,292,092       1,388,323       (148,248 )     1,240,075  
Gross profit     988,739       100,569       1,089,308       816,118       148,248       964,366  
Gross margin %     41.5 %         45.7 %     37.0 %         43.7 %
                         
Selling, general and administrative (2)     427,227       (38,117 )     389,110       380,369       (32,105 )     348,264  
Research and development (3)     145,774       (16,311 )     129,463       151,356       (5,576 )     145,780  
Intellectual property legal development expenses     5,822       —       5,822       6,221       —       6,221  
Acquisition and integration costs (4)     35,073       (35,073 )     —       —       —       —  
Restructuring and other charges     2,140       (1,389 )     751       1,738       (1,738 )     —  
Change in fair value of contingent consideration (5)     (6,000 )     6,000       —       —       —       —  
Charges for property losses and associated expenses (6)     5,369       (5,369 )     —       —       —       —  
Charges (credit) related to legal matters, net (7)     15,248       (16,251 )     (1,003 )     (390 )     390       —  
Other operating income     (8,870 )     —       (8,870 )     (5,239 )     —       (5,239 )
Operating income   $ 366,956     $ 207,079     $ 574,035     $ 282,063     $ 187,277     $ 469,340  

(1) Adjustments for the nine months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($3.1 million and $2.8 million), amortization expense ($95.6 million and $122.5 million), amortization of acquired inventory step-up ($0.9 million and none), and asset impairment charges ($1.0 million and $22.9 million).

(2) Adjustments for the nine months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($24.2 million and $18.4 million), amortization expense ($7.9 million and $8.1 million), site closure costs ($1.4 million and $1.6 million), and other ($4.6 million and $4.0 million).

(3) Adjustments for the nine months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($2.5 million and $2.4 million), asset impairment charges ($13.8 million and none), and site closure costs (none and $3.2 million).

(4) Acquisition and integration costs for the nine months ended September 30, 2026 were primarily related to professional services fees (e.g., investment banking, legal, due diligence, financial advisory, accounting, and consulting) associated with the acquisition and integration of Kashiv.

(5) During the nine months ended September 30, 2026, the Company recognized a $6.0 million gain related to the remeasurement of contingent consideration associated with the Kashiv Acquisition. The gain reflects the periodic remeasurement of the contingent consideration liability driven primarily by increases in the discount rate subsequent to the acquisition date.

(6) During the third week of July 2026, severe rain caused water damage to one of the Company’s facilities in India. Operations at this facility were temporarily suspended while the Company assessed the damage, completed remediation and repair activities, and restored operations. The Company concluded that certain property and equipment and inventory were damaged. The Company also incurred costs related to cleanup, repair and remediation. Accordingly, the Company recorded charges related to inventory and property losses and associated cleanup, repair and remediation costs.

(7) Adjustments to charges (credit) related to legal matters, net were $16.3 million for the nine months ended September 30, 2026, primarily consisting of (i) a $21.2 million charge associated with certain states electing a 25% cash conversion in lieu of product under the Nationwide Opioids Settlement Agreement, partially offset by a $20.8 million discount recorded on the expected settlement payments as of the agreement’s effective date, (ii) net charges associated with antitrust class action litigation of $7.5 million, (iii) a charge related to government investigations of $8.0 million, and (iv) immaterial net charges related to several matters.

Amneal Pharmaceuticals, Inc.
Affordable Medicines Segment
Reconciliation of GAAP to Non-GAAP Operating Results (1)
(unaudited; $ in thousands)

    Three Months Ended September 30, 2026   Three Months Ended September 30, 2025
    As Reported   Adjustments   Non-GAAP   As Reported   Adjustments   Non-GAAP
Net revenue   $ 547,109     $ —     $ 547,109     $ 460,741     $ —     $ 460,741  
Cost of goods sold (2)     352,331       (20,046 )     332,285       280,463       (12,075 )     268,388  
Gross profit     194,778       20,046       214,824       180,278       12,075       192,353  
Gross margin %     35.6 %         39.3 %     39.1 %         41.7 %
                         
Selling, general and administrative (3)     32,097       (2,857 )     29,240       37,173       (2,341 )     34,832  
Research and development (4)     63,418       (14,553 )     48,865       55,124       (679 )     54,445  
Intellectual property legal development expenses     2,138       —       2,138       2,378       —       2,378  
Restructuring and other charges     891       (891 )     —       90       (90 )     —  
Change in fair value of contingent consideration (5)     (6,000 )     6,000       —       —       —       —  
Charges for property losses and associated expenses (6)     5,334       (5,334 )     —       —       —       —  
Charges (credit) related to legal matters, net (7)     5,500       (7,500 )     (2,000 )     —       —       —  
Other operating income     (631 )     —       (631 )     (117 )     —       (117 )
Operating income   $ 92,031     $ 45,181     $ 137,212     $ 85,630     $ 15,185     $ 100,815  

(1) Revenue, cost of goods sold, and gross profit from the sale of Amneal products by AvKARE were included in our Affordable Medicines segment.

(2) Adjustments for the three months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($1.1 million in each period), amortization expense ($17.0 million and $10.4 million), amortization of acquired inventory step-up ($0.9 million and none), and asset impairment charges ($1.0 million and $0.6 million).

(3) Adjustments for the three months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($2.4 million and $1.8 million) and site closure costs ($0.4 million and $0.5 million).

(4) Adjustments for the three months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($0.8 million and $0.7 million) and asset impairment charges ($13.8 million and none).

(5) For the three months ended September 30, 2026, the Company recognized a $6.0 million gain related to the remeasurement of contingent consideration associated with the Kashiv Acquisition. The gain reflects the periodic remeasurement of the contingent consideration liability driven primarily by increases in the discount rate subsequent to the acquisition date.

(6) During the third week of July 2026, severe rain caused water damage to one of the Company’s facilities in India. Operations at this facility were temporarily suspended while the Company assessed the damage, completed remediation and repair activities, and restored operations. The Company concluded that certain property and equipment and inventory were damaged. The Company also incurred costs related to cleanup, repair and remediation. Accordingly, the Company recorded charges related to inventory and property losses and associated cleanup, repair and remediation costs.

(7) Adjustments to charges (credit) related to legal matters, net were $7.5 million for the three months ended September 30, 2026, primarily consisting of a charge related to government investigations of $8.0 million, partially offset by immaterial net credits related to several matters.

Amneal Pharmaceuticals, Inc.
Affordable Medicines Segment
Reconciliation of GAAP to Non-GAAP Operating Results (1)
(unaudited; $ in thousands)

    Nine Months Ended September 30, 2026   Nine Months Ended September 30, 2025
    As Reported   Adjustments   Non-GAAP   As Reported   Adjustments   Non-GAAP
Net revenue   $ 1,460,259     $ —     $ 1,460,259     $ 1,308,874     $ —     $ 1,308,874  
Cost of goods sold (2)     867,459       (44,129 )     823,330       775,742       (34,121 )     741,621  
Gross profit     592,800       44,129       636,929       533,132       34,121       567,253  
Gross margin %     40.6 %         43.6 %     40.7 %         43.3 %
                         
Selling, general and administrative (3)     115,782       (8,228 )     107,554       105,114       (6,340 )     98,774  
Research and development (4)     129,727       (15,955 )     113,772       128,003       (2,145 )     125,858  
Intellectual property legal development expenses     5,633       —       5,633       6,069       —       6,069  
Restructuring and other charges     891       (891 )     —       773       (773 )     —  
Change in fair value of contingent consideration (5)     (6,000 )     6,000       —       —       —       —  
Charges for property losses and associated expenses (6)     5,334       (5,334 )     —       —       —       —  
Charges (credit) related to legal matters, net (7)     14,251       (16,251 )     (2,000 )     (390 )     390       —  
Other operating income     (8,870 )     —       (8,870 )     (5,239 )     —       (5,239 )
Operating income   $ 336,052     $ 84,788     $ 420,840     $ 298,802     $ 42,989     $ 341,791  

(1) Revenue, cost of goods sold, and gross profit from the sale of Amneal products by AvKARE were included in our Affordable Medicines segment.

(2) Adjustments for the nine months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($3.1 million and $2.9 million), amortization expense ($39.1 million and $30.5 million), amortization of acquired inventory step-up ($0.9 million and none), and asset impairment charges ($1.0 million and $0.7 million).

(3) Adjustments for the nine months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($6.8 million and $4.7 million) and site closure costs ($1.4 million and $1.6 million).

(4) Adjustments for the nine months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($2.2 million and $2.1 million) and asset impairment charges ($13.8 million and none).

(5) For the nine months ended September 30, 2026, the Company recognized a $6.0 million gain related to the remeasurement of contingent consideration associated with the Kashiv Acquisition. The gain reflects the periodic remeasurement of the contingent consideration liability driven primarily by increases in the discount rate subsequent to the acquisition date.

(6) During the third week of July 2026, severe rain caused water damage to one of the Company’s facilities in India. Operations at this facility were temporarily suspended while the Company assessed the damage, completed remediation and repair activities, and restored operations. The Company concluded that certain property and equipment and inventory were damaged. The Company also incurred costs related to cleanup, repair and remediation. Accordingly, the Company recorded charges related to inventory and property losses and associated cleanup, repair and remediation costs.

(7) Adjustments to charges (credit) related to legal matters, net were $16.3 million for the nine months ended September 30, 2026, primarily consisting of (i) a $21.2 million charge associated with certain states electing a 25% cash conversion in lieu of product under the Nationwide Opioids Settlement Agreement, partially offset by a $20.8 million discount recorded on the expected settlement payments as of the agreement’s effective date, (ii) net charges associated with antitrust class action litigation of $7.5 million, (iii) a charge related to government investigations of $8.0 million, and (iv) immaterial net charges related to several matters.

Amneal Pharmaceuticals, Inc.
Specialty Segment
Reconciliation of GAAP to Non-GAAP Operating Results
(unaudited; $ in thousands)

    Three Months Ended September 30, 2026   Three Months Ended September 30, 2025
    As Reported   Adjustments   Non-GAAP   As Reported   Adjustments   Non-GAAP
Net revenue   $ 150,262     $ —     $ 150,262     $ 125,240     $ —     $ 125,240  
Cost of goods sold (1)     46,212       (18,895 )     27,317       73,808       (48,607 )     25,201  
Gross profit     104,050       18,895       122,945       51,432       48,607       100,039  
Gross margin %     69.2 %         81.8 %     41.1 %         79.9 %
                         
Selling, general and administrative (2)     36,969       (657 )     36,312       33,580       (490 )     33,090  
Research and development (3)     4,956       (132 )     4,824       8,228       (1,843 )     6,385  
Intellectual property legal development expenses     55       —       55       59       —       59  
Restructuring and other charges     —       —       —       —       —       —  
Charges for property losses and associated expenses     35       (35 )     —       —       —       —  
Charges related to legal matters, net     1,000       —       1,000       —       —       —  
Operating income   $ 61,035     $ 19,719     $ 80,754     $ 9,565     $ 50,940     $ 60,505  

(1) Adjustments for the three months ended September 30, 2026 and 2025, respectively, were comprised of amortization expense ($18.9 million and $26.5 million) and asset impairment charges (none and $22.1 million).

(2) Adjustments for the three months ended September 30, 2026 and 2025 were comprised of stock-based compensation expense.

(3) Adjustments for the three months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($0.1 million in each period) and site closure costs (none and $1.7 million).

Amneal Pharmaceuticals, Inc.
Specialty Segment
Reconciliation of GAAP to Non-GAAP Operating Results
(unaudited; $ in thousands)

    Nine Months Ended September 30, 2026   Nine Months Ended September 30, 2025
    As Reported   Adjustments   Non-GAAP   As Reported   Adjustments   Non-GAAP
Net revenue   $ 432,822     $ —     $ 432,822     $ 361,580     $ —     $ 361,580  
Cost of goods sold (1)     137,497       (56,440 )     81,057       182,686       (114,127 )     68,559  
Gross profit     295,325       56,440       351,765       178,894       114,127       293,021  
Gross margin %     68.2 %         81.3 %     49.5 %         81.0 %
                         
Selling, general and administrative (2)     111,755       (1,847 )     109,908       94,872       (1,321 )     93,551  
Research and development (3)     16,047       (357 )     15,690       23,353       (3,430 )     19,923  
Intellectual property legal development expenses     189       —       189       152       —       152  
Restructuring and other charges     347       (347 )     —       471       (471 )     —  
Charges for property losses and associated expenses     35       (35 )     —       —       —       —  
Charges related to legal matters, net     1,000       —       1,000       —       —       —  
Operating income   $ 165,952     $ 59,026     $ 224,978     $ 60,046     $ 119,349     $ 179,395  

(1) Adjustments for the nine months ended September 30, 2026 and 2025, respectively, were comprised of amortization expense ($56.4 million and $92.0 million) and asset impairment charges (none and $22.1 million).

(2) Adjustments for the nine months ended September 30, 2026 and 2025 were comprised of stock-based compensation expense.

(3) Adjustments for the nine months ended September 30, 2026 and 2025, respectively, were comprised of stock-based compensation expense ($0.4 million and $0.3 million) and site closure costs (none and $3.1 million).

Amneal Pharmaceuticals, Inc.
AvKARE Segment
Reconciliation of GAAP to Non-GAAP Operating Results (1)
(unaudited; $ in thousands)

    Three Months Ended September 30, 2026   Three Months Ended September 30, 2025
    As Reported   Adjustments   Non-GAAP   As Reported   Adjustments   Non-GAAP
Net revenue   $ 165,313     $ —     $ 165,313     $ 198,532     $ —     $ 198,532  
Cost of goods sold     130,023       —       130,023       156,268       —       156,268  
Gross profit     35,290       —       35,290       42,264       —       42,264  
Gross margin %     21.3 %         21.3 %     21.3 %         21.3 %
                         
Selling, general and administrative (2)     17,919       (2,647 )     15,272       15,234       (2,699 )     12,535  
Operating income   $ 17,371     $ 2,647     $ 20,018     $ 27,030     $ 2,699     $ 29,729  

(1) Revenue, cost of goods sold, and gross profit from the sale of Amneal products by AvKARE were included in our Affordable Medicines segment.

(2) Adjustments for the three months ended September 30, 2026 and 2025 were comprised of amortization expense.

Amneal Pharmaceuticals, Inc.
AvKARE Segment
Reconciliation of GAAP to Non-GAAP Operating Results (1)
(unaudited; $ in thousands)

    Nine Months Ended September 30, 2026   Nine Months Ended September 30, 2025
    As Reported   Adjustments   Non-GAAP   As Reported   Adjustments   Non-GAAP
Net revenue   $ 488,319     $ —     $ 488,319     $ 533,987     $ —     $ 533,987  
Cost of goods sold     387,705       —       387,705       429,895       —       429,895  
Gross profit     100,614       —       100,614       104,092       —       104,092  
Gross margin %     20.6 %         20.6 %     19.5 %         19.5 %
                         
Selling, general and administrative (2)     51,512       (7,943 )     43,569       46,007       (8,099 )     37,908  
Operating income   $ 49,102     $ 7,943     $ 57,045     $ 58,085     $ 8,099     $ 66,184  

(1) Revenue, cost of goods sold, and gross profit from the sale of Amneal products by AvKARE were included in our Affordable Medicines segment.

(2) Adjustments for the nine months ended September 30, 2026 and 2025 were comprised of amortization expense.

All of the amounts disclosed in this press release are in U.S. dollars unless otherwise noted

TEL AVIV, Israel, Nov. 03, 2026 (GLOBE NEWSWIRE) — Enlight Renewable Energy (NASDAQ: ENLT, TASE: ENLT) today reported financial results for the quarter ended September 30, 2026. Registration links for the Company’s earnings English and Hebrew conference call and webcasts can be found at the end of this earnings release.

The entire suite of the Company’s 3Q26 financial results can be found on our IR website at https://enlightenergy.com/data/financial-reports/
 

Financial Highlights

3 months ending September 30, 2026

  • Total revenues and income1 of $231 million, an increase of 40% compared to the same period last year.
  • Net income of $34 million, compared to $32 million in the same period last year. Excluding one-time items, net income increased by 76%.
  • Adjusted EBITDA2 of $154 million, compared to $112 million in the same period last year, an increase of 38%.
  • Cash flow from operating activities3 of about $104 million, an increase of 26% compared to the same period last year.

9 months ending September 30, 2026

  • Total revenues and income of $641 million, an increase of 49% compared to the same period last year.
  • Net income of $103 million, compared to $140 million in the same period last year. Excluding a gain of approximately $81 million recorded in the corresponding period as a result of the sale of 44% of the Sunlight portfolio and the resulting loss of control, as well as other one-time items, net income increased by approximately 122%.
  • Adjusted EBITDA of $468 million, compared to $339 million in the first nine months of 2025, an increase of 38%. Excluding a $42 million gain from the sale of 44% of the Sunlight portfolio in the first half of 2025 and a gain of approximately $30 million from subsequent sales of approximately 26% of the Sunlight portfolio in the first half of 2026, Adjusted EBITDA for the first nine months of 2026 increased by 48% compared with the corresponding period last year.
  • Operating cash flow of $289 million, an increase of 39% compared with the corresponding period last year.

2026 guidance raised

  • The Company is raising and narrowing its guidance range for 2026. Revenues & income4 are expected to range between $810 million and $830 million, compared with the previous guidance range of $790 million to $820 million.
  • Adjusted EBITDA guidance increased to $575 to $590 million, up from $565 to $585 million previously.
  • The guidance increase primarily reflects operating results for the first nine months, electricity trading activity in Israel and higher electricity prices in Europe.

1Total revenues and income include revenues from the sale of electricity, as well as income from tax benefits from U.S. projects

2Adjusted EBITDA is a non-IFRS measure. Please refer to the appendices for the reconciliation to net income. The Company is unable to provide a reconciliation of “Adjusted EBITDA” to net income on a forward-looking basis without unreasonable effort because items that impact this IFRS financial measure are not within the Company’s control and/or cannot be reasonably predicted

3Interest payments and receipts are classified as cash flows from financing and investing activities, respectively, instead of cash flows from operating activities. Adjustments were made to comparative figures due to a change in accounting policy; for further details, see Appendix No. 4

4Total revenues and income include revenues from the sale of electricity along with income from tax benefits from US projects amounting to $160-180m.

Summary of key financial results:

  For the three months ended For the nine months ended
($ millions) September 30,
2026
September 30,
2025
% change September 30,
2026
September 30,
2025
% change
Revenues and Income 231 165 40% 641 430 49%
Net Income 34 32 4% 103 140 (27%)
Adjusted EBITDA 154 112 38% 468 339 38%
Adjusted EBITDA excluding the Sunlight transactions 154 112 38% 438 297 48%
Cash Flow from Operating Activities 104 83 26% 289 208 39%
             

Adi Leviatan, CEO of Enlight Renewable Energy: “We conclude another quarter of strong growth and consistent execution, with total revenue and income increasing by 40%, Adjusted EBITDA increasing by 38%, and cash flow from operating activities of $289 million in the first nine months of the year. In Europe, we are benefiting from higher electricity prices and continue to expand our energy storage activity with additional projects that generate double-digit project-level returns. In the U.S., all five phases of the approximately 2.4 FGW CO-Bar complex are now under construction following the closing of the largest financing transaction in the Company’s history, and we continue to expand our presence in markets east of WECC. Our strong results, solid balance sheet and growing cash flow provide a solid foundation for continued growth and enable us to raise our 2026 guidance once again.”

Portfolio Review

During the third quarter and through the date of this release, Enlight continued to expand its portfolio and advance projects through the various phases of development. As of the earnings release date, Enlight’s total portfolio is comprised of 23.1 GW of generation capacity and 80.9 GWh energy storage capacity (totaling 46.2 FGW5), representing an increase of 7.1% compared to the total portfolio at the release date of the second quarter of 2026 (43.1 FGW). The generation component increased by approximately 5.9%, while the storage component increased by approximately 8.4% compared with the previous quarter. This increase reflects Enlight’s strategy of taking a leading position in energy storage in response to growing needs in global markets.

The mature portfolio component (operating, under-construction and pre-construction projects) comprises 6.4 GW of generation capacity and 21.7 GWh of energy storage capacity, totaling 12.7 FGW, compared with 12.3 FGW at the end of the previous quarter, a sequential increase of approximately 3%. Approximately 52% of the capacity in the mature portfolio is located in the United States, approximately 33% in Europe and approximately 15% in MENA.

Enlight has identified energy storage as one of its key growth engines in Europe, against the backdrop of accelerating renewable-energy penetration and the increasing need for grid flexibility and balancing. To establish an early-mover advantage in attractive markets, during the past year the Company increased its European storage portfolio by 6.6 GWh and expanded its operations into four new countries: Germany, Poland, Romania and Finland. This expansion is expected to add approximately $300 million to the annual revenue run rate and bring expected revenues from the mature European portfolio to approximately $630 million per year.

The advanced-development and development portfolio comprises 16.6 GW of generation capacity and 59.1 GWh of storage capacity, totaling 33.5 FGW, an increase of approximately 9% compared with the previous quarter. Approximately 73% of the capacity in these components is located in the United States, approximately 15% in MENA and approximately 12% in Europe.

In the United States, approximately 40% of the advanced-development and development portfolio is located in PJM, SPP and MISO. Expanding the Company’s presence in integrated markets east of WECC provides exposure to accelerated electricity-demand growth, driven in part by data-center expansion and the emergence of BYOG (Bring Your Own Generation) regulation in PJM and SPP. Alongside higher PPA prices, these markets allow the Company to broaden its customer base and are expected to enable it to operate under a merchant model for the first time in the U.S., thereby benefiting from potential upside in electricity prices and greater flexibility in optimizing revenues from projects that combine generation and energy storage.

5FGW (Factored GW) is the company’s consolidated metric combining generation and storage capacity into a uniform figure based on the ratio of construction costs. Current weighted average construction cost ratio is 3.5 GWh of storage per 1 GW of generation: FGW = GW + GWh / 3.5.

The composition of Enlight’s portfolio appears in the following table:

Component Status FGW Annual revenues &
income run rate ($m)
Operating Commercial operation 4 ~810-820
Under construction Under construction 5.6 ~1,050
Pre-construction 0-12 months to start of construction 3.1 ~500
Total Mature Portfolio   12.7 ~$2,365m
Advanced development 13-24 months to start of construction 8.6 –
Development 24+ months to start of construction 24.9 –
Total Portfolio   46.2 –
       
  • Operating component of the portfolio: 4.0 FGW
    • Approximately 41% of the operating component is in the U.S., 34% in Europe, and 25% in Israel. Approximately 90% of operating capacity is contracted under PPAs, of which approximately 24% is under index-linked PPAs.
    • During the quarter, two projects commenced operations, with a combined annual revenue run rate of approximately $8 million: the Sestanovac project in Croatia, with 23 FMW of generation capacity and 75 MWh of storage capacity (45 FMW), and the Qunaitra project in Israel, with 15 FMW (primarily storage).
    • The operating portfolio generates annualized revenues and income run rate of approximately $810 to $820 million. The increase reflects higher electricity-trading revenues in Israel, higher electricity prices and the commencement of operations at the projects described above.
  • Under construction component of the portfolio: 5.6 FGW
    • Net of projects that commenced operations, this component increased quarter-over-quarter by approximately 1.2 FGW, or approximately 26%.
    • During the quarter, construction commenced on phases 4 and 5 of the CO-Bar project in Arizona, comprising 3,176 MWh of stand-alone storage capacity (907 FMW). As of the publication of the third-quarter reports, all five phases of the approximately 2.4 FGW CO-Bar project are under construction. The project is expected to commence operations in stages, beginning in the fourth quarter of 2027 and continuing through the first half of 2028.
    • Construction also commenced on two projects in Israel: Ohad high-voltage energy storage project with 193 FMW and the Nahal Oz project with capacity of 56 FMW.
    • The under-construction component includes eight projects in the U.S. (5 phases of the CO Bar complex, Country Acres, Crimson Orchard, and Snowflake A) with a total capacity of 4.3 FGW, six projects in Europe with an aggregate capacity of approximately 0.9 FGW, and projects in Israel with a total capacity of approximately 370 FMW.
    • Energy storage projects (either standalone or paired with generation assets) account for approximately 53% of the under-construction component.
    • The Company estimates that construction of an additional approximately 1.3 FGW will commence during the remainder of 2026, such that 86% of the mature portfolio component is expected to be operating or under construction by year-end.
    • The under-construction component is expected to contribute approximately $1,050 million to the annual revenues and income in its first full year of operation, compared with $840 million in the previous quarter. The increase is mainly attributable to the inclusion of the projects mentioned above.
  • Pre-construction component of the portfolio: 3.1 FGW
    • Net of 1,156 FMW of projects that moved into construction, this component increased by approximately 14%, or 347 FMW.
    • During the quarter, two additional energy storage projects in Finland with aggregate capacity of 858 MWh (245 FMW) were acquired and added to the three projects acquired in Finland in the second quarter with a total capacity of 542 MWh. Commercial operation is expected during the first half of 2028, and the projects are expected to generate unlevered returns of 19%-21%. The increase in expected returns compared with the previous quarter reflects lower equipment costs.
    • During the quarter, projects in Israel and Poland totaling approximately 102 FMW moved from advanced development to the pre-construction stage.
    • The pre-construction component includes three projects in the U.S. totaling approximately 567 FMW, thirteen projects in Europe totaling approximately 2.0 FGW (88% of which is energy storage), and projects in Israel totaling approximately 572 FMW.
    • Storage projects account for 71% of total capacity.
    • Pre-construction projects are expected to contribute approximately $500 million to the annual recurring revenues and income in their first full year of operation.
  • Advanced development component of the portfolio: 8.6 FGW
    • This component increased by approximately 820 FMW (approximately 11%) compared with the previous quarter.
    • During the quarter, projects totaling 509 FMW in Israel moved into advanced development.
    • This component includes approximately 6 FGW in the United States, 1.1 FGW in Europe and 1.4 FGW in MENA.
    • Storage projects represent approximately 53% of capacity.
    • During the quarter, the Company made significant progress on its Blackwater project in Virginia, U.S., Enlight’s flagship project in PJM, by obtaining a key county permit and securing a 500 MW grid interconnection. The planned project comprises 600 MW of solar generation with a potential to add 2,000 MWh of energy storage capacity (1.2 FGW in total). It is located in an area experiencing significant electricity-demand growth, including demand from data centers, and is expected to strengthen Enlight’s position in one of the major integrated power markets in the eastern U.S. The Company is also evaluating the potential to double the project’s capacity in the future, executing on its connect-and-expand strategy.
    • As of the date of this report, the entire advanced development portfolio in the U.S. has successfully completed System Impact Study process and has a high likelihood of securing grid interconnection.
    • Approximately 5 FGW of U.S. capacity met Safe Harbor6 requirements (approximately 83% of this component’s capacity in the U.S.), securing eligibility for tax benefits.

    6Securing Safe Harbor status and grid interconnection agreement do not guarantee the project’s completion. Actual project completion is subject to meeting development milestones and market conditions

  • Development component of the portfolio: 24.9 FGW
    • This component includes 18.4 FGW in the U.S., 3.7 FGW in MENA, and 2.8 FGW in Europe.
    • The main additions over the past three months include approximately 2.1 FGW in the United States, across PJM, MISO and WECC, as well as 590 FMW in MENA and 100 FMW in Europe.
    • Storage projects account for approximately 50% of total capacity.
    • As of the publication of the quarterly results, 8.8 FGW (approximately 48% of U.S. capacity in this component) had completed a System Impact Study and has a high probability of securing grid interconnection.
    • Approximately 6.4 FGW of U.S. capacity met Safe Harbor requirements (approximately 35% of this component’s capacity in the U.S.), securing eligibility for tax benefits.
    • Under current U.S. legislation, energy storage projects that commence construction by the end of 2033 are eligible for the full value of available tax credits, with a gradual phase-down for projects beginning construction during the following three years. The Company currently has approximately 5.7 FGW of energy storage capacity in its portfolio that is expected to begin construction over the coming years.
    • The Company expects to pursue similar tax credit eligibility for future energy storage projects added to its portfolio, subject to their commencement of construction within the applicable qualification period.

Enlight’s operating capacity is expected to reach approximately 12 FGW, and total annual revenues and income7 run rate is expected to reach $2.2 to $2.3 billion by the end of 2028, reflecting a 41% compound annual growth rate between 2024 and 2028.

Roadmap to Revenues and Income Run-Rate of ~$2.2-2.3bn by the end of 2028

7The expected growth in 2028 encompasses the Company’s operations in all geographies. Expected growth relies on business plans which rely on development conditions and assumptions regarding electricity prices and are contingent on current trends known to the Company at this time; Expected Adjusted EBITDA margin of approximately 70%-80% (including tax benefits) for the years shown. The company’s revenues from tax benefits are estimated at approximately 23-25% of the total revenue run rate for December 2026, and approximately 28-31% of the total revenues & income run rate for December 2027 and December 2028; The gap between revenues & income in the mature portfolio and 2028 ARR stems from mature projects completing construction in 2029

Corporate and Project Financing

  • During the first nine months of the year, the Company secured approximately $3.7 billion in financing sources, including project financing:
    • $2.6 billion financing for the CO-Bar complex, representing the largest financing transaction in the Company’s history.
    • Approximately $350 million raised through an expansion of Series G bonds on the Tel Aviv Stock Exchange, at an interest rate of approximately 4.4%, reflecting a spread of approximately 0.75% above comparable Israeli government bonds.
    • Issuance of approximately 6 million shares to Israeli institutional investors, generating gross proceeds of approximately $420 million.
    • $304 million financing secured for the Crimson Orchard project in Idaho, U.S.
    • Follow-on transactions for the sale of additional stakes in the Sunlight portfolio, generating proceeds of $38 million.
  • During the quarter, the Company repaid Series F bonds totaling $185 million.
  • As of the balance sheet date, cash and cash equivalents at the “topco” level8 totaled $420 million. In addition, cash and cash equivalents held by subsidiaries amounted to approximately $316 million.
  • As of the balance sheet date, the Company had available credit facilities of $520 million, of which $48 million had been utilized.
  • As of the balance sheet date, the Company had approximately $1.8 billion of Letter of Credit and Surety Bond facilities, of which $630 million had been utilized.
  • The Company’s consolidated long-term debt amounts to approximately $5.6 billion, of which approximately 80% is non-recourse project financing and approximately 86% is at fixed interest rates, including through hedging arrangements. This financing structure significantly reduces the Company’s exposure to interest rate fluctuations. As a result, the Company estimates that an increase in risk-free interest rates would have a very limited impact on its operating results and on the returns of projects within the mature portfolio.

8 Including Enlight Renewable Energy, headquarter companies in Europe and the U.S. and Clenera, and excluding other subsidiaries and project-linked entities.

Financial Results Analysis

Revenues & Income by Segment
($ millions) For the three months ended For the nine months ended
Segment September 30,
2026
September 30,
2025
% change September 30,
2026
September 30,
2025
% change
MENA 99 78 27% 240 173 39%
Europe 52 45 16% 165 145 14%
U.S. 80 42 90% 234 111 111%
Other – – – 2 1 100%
Total Revenues & Income 231 165 40% 641 430 49%
             

Revenues & Income

In the third quarter of 2026, the Company’s total revenues & income increased by 40% to approximately $231 million, compared with approximately $165 million in the corresponding period last year. Revenues from the sale of electricity increased by approximately 35% to approximately $187 million. The increase was primarily attributable to new projects, which contributed approximately $21 million, foreign-exchange effects, which contributed $9 million, and electricity trading activity in Israel, which contributed $17 million (excluding foreign-exchange effects).

Electricity trading activity in Israel more than doubled compared with the corresponding periods last year and generated revenues of approximately $56 million in the third quarter and approximately $114 million in the first nine months of 2026, of which 40% are revenues from electricity generated in Enlight’s projects in Israel. The increase reflected expansion of the customer base in Israel, together with strong seasonal summer demand. Electricity trading provides an additional business both for electricity generated by our assets and for electricity purchased from other producers or from the grid, thereby broadening the monetization options for generation in accordance with market conditions. Although the activity is characterized by low margins, it also carries low risk, relies on an existing platform and does not require fixed costs. It therefore supports value maximization and enhances the overall returns of Enlight’s asset portfolio in Israel.

In the U.S., tax-benefit revenues amounted to approximately $45 million, compared with approximately $27 million in the corresponding quarter last year. The increase was attributable to new projects that commenced operations at the end of 2025.

Net Income

The Company’s net income in the third quarter of 2026 amounted to $34 million, compared with $32 million in the corresponding period last year. During the quarter, the Company’s management decided to terminate two PPAs for the Rustic Hills and Gemstone projects in the United States, with a combined capacity of 439 FMW. These were the last remaining projects in the Company’s U.S. portfolio with legacy PPAs. The decision followed prolonged negotiations with the offtakers and reflected the significant shift in U.S. market conditions over the past year, particularly higher prevailing PPA prices, alongside increases in equipment costs and tariffs. Accordingly, in the third quarter the Company recorded a one-time termination expense of $20 million before tax.

The $66 million increase in revenues compared with the corresponding quarter was partially offset by a $23 million increase in cost of revenues, mainly related to the expansion of electricity trading activity and new operating projects, a $3 million increase in general and administrative and development expenses, a $9 million increase in depreciation expense following the commencement of operations of new projects and a $12 million increase in other expenses (primarily related to the PPAs termination fees described above, offset by a compensation and an advance payment refund from a supplier). In addition, finance expenses increased by $20 million, primarily due to a $13 million gain related to the refinancing of the Gecama project in Spain recorded in the comparable quarter last year.

Excluding the cost associated with the termination of the PPAs, the compensation and refund of an advance payment from a supplier, and the financing income related to the refinancing of the Gecama project in the prior-year period, net income increased by 76% in the third quarter compared to the same period last year.

Adjusted EBITDA

The Company’s Adjusted EBITDA for the third quarter of 2026 amounted to approximately $154 million, compared with approximately $112 million in the corresponding period last year, an increase of 38%. The increase compared with the third quarter of 2025 resulted from the $66 million increase in revenues, offset by a $22 million increase in cost of sales due to the expansion of electricity trading activity in Israel and the commencement of operations at new projects; a $3 million increase in general and administrative and development expenses, excluding share-based payment expenses; and a $2 million increase in other expenses.

Conference Call Information

English Conference Call & Webcast at 8:00am ET / 3:00pm Israel:

Please pre-register to join the live conference call:

https://register-conf.media-server.com/register/BIf60e72c108f7438789f445795b04ba52

Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN.

To join by webcast and follow the presentation, please use the following link: 

https://edge.media-server.com/mmc/p/xho8qjz7

Hebrew Webcast at 6:00am ET / 1:00pm Israel:

Please pre-register to join the live webcast:

Webinar Registration – Zoom

The press release with the financial results as well as the investor presentation materials will be accessible from the Company’s website prior to the conference call. An archived version of the webcast will be available on the Company’s investor relations website at https://enlightenergy.com/info/investors/

Supplemental Financial and Other Information

We intend to announce material information to the public through the Enlight investor relations website at https://enlightenergy.com/info/investors, SEC filings, press releases, public conference calls, and public webcasts. We use these channels to communicate with our investors, customers, and the public about our company, our offerings, and other issues. As such, we encourage investors, the media, and others to follow the channels listed above, and to review the information disclosed through such channels. Any updates to the list of disclosure channels through which we will announce information will be posted on the investor relations page of our website.

Non-IFRS Financial Measures

This release presents Adjusted EBITDA, a non-IFRS financial metric, which is provided as a complement to the results provided in accordance with the International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS”). A reconciliation of the non-IFRS financial information to the most directly comparable IFRS financial measure is provided in the accompanying tables found at the end of this release.

We define Adjusted EBITDA as net income (loss) plus depreciation and amortization, share based compensation, finance expenses, taxes on income and share in losses of equity accounted investees, minus finance income and adjusted to eliminate any non-recurring portions of other income (expenses), net. compensation received in respect of contractual performance shortfalls and recorded in other income (expenses), net, is included in adjusted EBITDA. Such compensation represents income the company would have generated had the contractual performance levels been achieved. With respect to gains (losses) from asset disposals, as part of Enlight’s strategy to accelerate growth and reduce the need for equity financing, the Company sells parts of or the entirety of selected renewable project assets from time to time, and therefore includes realized gains or losses from these asset disposals in Adjusted EBITDA. In the case of partial assets disposals, Adjusted EBITDA includes only the economic gain or loss attributable to the interest sold, calculated as the consideration received less the proportional book value attributable to such interest. Our management believes Adjusted EBITDA is indicative of operational performance and ongoing profitability and uses Adjusted EBITDA to evaluate the operating performance and for planning and forecasting purposes.

Non-IFRS financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under IFRS. There are a number of limitations related to the use of non-IFRS financial measures versus comparable financial measures determined under IFRS. For example, other companies in our industry may calculate the non-IFRS financial measures that we use differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of our non-IFRS financial measures as analytical tools. Investors are encouraged to review the related IFRS financial measure, Net Income, and the reconciliations of Adjusted EBITDA provided below to Net Income and to not rely on any single financial measure to evaluate our business.

Special Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding the Company’s business strategy and plans, capabilities of the Company’s project portfolio and the Company’s expectation relating to projects, including their timeline, financing and the achievement of operational and financial objectives, market opportunity, utility demand and potential growth, discussions with commercial counterparties and financing sources, pricing trends for materials, progress of Company projects, including anticipated timing of related approvals and project completion and anticipated production delays, the Company’s future financial results, expected impact from various regulatory developments and anticipated trade sanctions, expectations regarding wind production, electricity prices and windfall taxes, and expected Revenues, Income and Adjusted EBITDA guidance, the expected timing of completion of our ongoing projects, and the Company’s anticipated cash requirements and financing plans , are forward-looking statements. The words “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “target,” “seek,” “believe,” “estimate,” “predict,” “potential,” “continue,” “contemplate,” “possible,” “forecasts,” “aims” or the negative of these terms and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. 

These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: our ability to site suitable land for, and otherwise source, renewable energy projects and to successfully develop and convert them into Operational Projects, as well as timing of construction of any project; availability of, and access to, interconnection facilities and transmission systems; our ability to obtain and maintain governmental and other regulatory approvals and permits, including environmental approvals and permits; construction delays, operational delays and supply chain disruptions leading to increased cost of materials required for the construction of our projects, as well as cost overruns and delays related to disputes with contractors; disruptions in trade caused by political, social or economic instability in regions where our components and materials are made; our suppliers’ ability and willingness to perform both existing and future obligations; competition from traditional and renewable energy companies in developing renewable energy projects; potential slowed demand for renewable energy projects and our ability to enter into new offtake contracts on acceptable terms and prices as current offtake contracts expire; offtakers’ ability to terminate contracts or seek other remedies resulting from failure of our projects to meet development, operational or performance benchmarks; exposure to market prices in some of our offtake contracts; various technical and operational challenges leading to unplanned outages, reduced output, interconnection or termination issues; the dependence of our production and revenue on suitable meteorological and environmental conditions, and our ability to accurately predict such conditions; our ability to enforce warranties provided by our counterparties in the event that our projects do not perform as expected; government curtailment, energy price caps and other government actions that restrict or reduce the profitability of renewable energy production; electricity price volatility, unusual weather conditions (including the effects of climate change, could adversely affect wind and solar conditions), catastrophic weather-related or other damage to facilities, unscheduled generation outages, maintenance or repairs, unanticipated changes to availability due to higher demand, shortages, transportation problems or other developments, environmental incidents, or electric transmission system constraints and the possibility that we may not have adequate insurance to cover losses as a result of such hazards; our dependence on certain operational projects for a substantial portion of our cash flows; our ability to continue to grow our portfolio of projects through successful acquisitions; changes and advances in technology that impair or eliminate the competitive advantage of our projects or upsets the expectations underlying investments in our technologies; our ability to effectively anticipate and manage cost inflation, interest rate risk, currency exchange fluctuations and other macroeconomic conditions that impact our business; our ability to retain and attract key personnel; our ability to manage legal and regulatory compliance and litigation risk across our global corporate structure; our ability to protect our business from, and manage the impact of, cyber-attacks, disruptions and security incidents, as well as acts of terrorism or war; changes to existing renewable energy industry policies and regulations that present technical, regulatory and economic barriers to renewable energy projects; the reduction, elimination or expiration of government incentives for, or regulations mandating the use of, renewable energy; our ability to effectively manage the global expansion of the scale of our business operations; our ability to perform to expectations in our new line of business involving the construction of PV systems for municipalities in Israel; our ability to effectively manage our supply chain and comply with applicable regulations with respect to international trade relations, the impact of tariffs on the cost of construction and our ability to mitigate such impact, sanctions, export controls and anti-bribery and anti-corruption laws; our ability to effectively comply with Environmental Health and Safety and other laws and regulations and receive and maintain all necessary licenses, permits and authorizations; our performance of various obligations under the terms of our indebtedness (and the indebtedness of our subsidiaries that we guarantee) and our ability to continue to secure project financing on attractive terms for our projects; limitations on our management rights and operational flexibility due to our use of tax equity arrangements; potential claims and disagreements with partners, investors and other counterparties that could reduce our right to cash flows generated by our projects; our ability to comply with increasingly complex tax laws of various jurisdictions in which we currently operate as well as the tax laws in jurisdictions in which we intend to operate in the future; our ability to obtain tax benefits and credits in the U.S. or other jurisdictions; the unknown effect of the dual listing of our ordinary shares on the price of our ordinary shares; various risks related to our incorporation and location in Israel, including the ongoing war in Israel, where our headquarters and some of our wind energy and solar energy projects are located; the costs and requirements of being a public company, including the diversion of management’s attention with respect to such requirements; certain provisions in our Articles of Association and certain applicable regulations that may delay or prevent a change of control; and other risk factors set forth in the section titled “Risk factors” in our Annual Report on Form 20-F for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission (the “SEC”), as may be updated in our other documents filed with or furnished to the SEC. 

These statements reflect management’s current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by applicable law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

About Enlight

Founded in 2008, Enlight develops, finances, constructs, owns, and operates utility-scale renewable energy projects. Enlight operates across the three largest renewable segments today: solar, wind and energy storage. A global platform, Enlight operates in the United States, Israel and 12 European countries. Enlight has been traded on the Tel Aviv Stock Exchange since 2010 (TASE: ENLT) and completed its U.S. IPO (Nasdaq: ENLT) in 2023.

Company Contacts

Limor Zohar Megen
Director IR
investors@enlightenergy.com

Erica Mannion or Mike Funari
Sapphire Investor Relations, LLC
+1 617 542 6180
investors@enlightenergy.com

Appendix 1 – Financial information

Consolidated Statements of Income

  For the nine months ended
September 30
  For the three months ended
September 30
 
  2026   2025   2026   2025  
  USD in   USD in   USD in   USD in  
  thousands   thousands   thousands   thousands  
                 
Revenues 509,188   364,411   186,711   138,536  
Tax benefits 131,465   65,493   44,658   26,521  
Total revenues and income 640,653   429,904   231,369   165,057  
                 
Cost of sales (*) (154,680)   (95,839)   (61,900)   (39,355)  
Depreciation and amortization (146,580)   (110,159)   (48,474)   (39,142)  
General and administrative expenses (54,684)   (38,968)   (17,603)   (15,632)  
Development expenses (12,634)   (8,373)   (3,945)   (2,904)  
Total operating expenses (368,578)   (253,339)   (131,922)   (97,033)  
Gains (losses) from projects disposals 889   96,431   –   (1,397)  
Other income (expenses), net (4,598)   5,785   (8,279)   3,411  
Operating profit 268,366   278,781   91,168   70,038  
Finance income 28,044   36,292   7,784   28,126  
Finance expenses (158,761)   (136,457)   (54,207)   (54,171)  
Total finance expenses, net (130,717)   (100,165)   (46,423)   (26,045)  
Profit before tax and equity loss 137,649   178,616   44,745   43,993  
Share of losses of equity accounted investees (1,709)   (3,904)   (288)   (2,259)  
Profit before income taxes 135,940   174,712   44,457   41,734  
Taxes on income (33,439)   (35,083)   (10,941)   (9,477)  
Profit for the period 102,501   139,629   33,516   32,257  
Profit for the period attributed to:                
Owners of the Company 82,888   117,841   29,446   22,026  
Non-controlling interests 19,613   21,788   4,070   10,231  
  102,501   139,629   33,516   32,257  
Earnings per ordinary share (in USD) with a par value of NIS 0.1, attributable to owners of the parent Company:                
Basic earnings per share 0.6   0.97   0.21   0.18  
Diluted earnings per share 0.56   0.91   0.2   0.16  
Weighted average of share capital used in the calculation of earnings:                
Basic per share 138,132,711   121,114,109   139,782,554   125,060,939  
Diluted per share 148,741,077   129,253,408   149,957,154   134,366,872  
.                
(*) Excluding depreciation and amortization.

Consolidated Statements of Financial Position as of        
         
  September 30   December 31  
  2026   2025  
  USD in   USD in  
  Thousands   Thousands  
Assets        
         
Current assets        
Cash and cash equivalents 736,332   528,497  
Restricted cash 153,628   409,424  
Trade receivables 119,223   95,118  
Other receivables 122,008   62,286  
Other financial assets 4,599   524  
Total current assets 1,135,790   1,095,849  
         
Non-current assets        
Restricted cash 118,407   130,358  
Other long-term receivables 80,993   64,349  
Deferred costs in respect of projects 419,570   235,615  
Deferred borrowing costs 275   1,749  
Loans to investee entities 87,997   85,131  
Investments in equity accounted investees 46,026   59,310  
Fixed assets, net 8,169,564   6,281,418  
Intangible assets, net 337,936   303,971  
Deferred taxes assets 4,674   4,692  
Right-of-use asset, net 263,844   225,495  
Financial assets at fair value through profit or loss 120,265   83,582  
Other financial assets 244,938   58,383  
Total non-current assets 9,894,489   7,534,053  
         
Total assets 11,030,279   8,629,902  

         
Consolidated Statements of Financial Position as of (Cont.)      
         
  September 30   December 31  
  2026   2025  
  USD in   USD in  
  Thousands   Thousands  
Liabilities and equity        
         
Current liabilities        
Credit and current maturities of loans from 517,458   884,120  
banks and other financial institutions        
Trade payables 247,047   137,230  
Other payables 510,338   405,741  
Current maturities of debentures 192,130   173,571  
Current maturities of lease liability 13,140   12,396  
Other financial liabilities 31,819   16,147  
Total current liabilities 1,511,932   1,629,205  
         
Non-current liabilities        
Debentures 639,830   477,315  
Other financial liabilities 137,525   378,303  
Convertible debentures 276,155   273,801  
Loans from banks and other financial institutions 4,640,260   2,981,786  
Loans from non-controlling interests 79,166   86,946  
Financial liabilities through profit or loss 27,828   26,946  
Deferred taxes liabilities 148,929   77,688  
Other payables 11,195   1,645  
Lease liability 272,837   231,135  
Deferred income related to tax equity 559,927   370,734  
Asset retirement obligation 100,361   99,460  
Total non-current liabilities 6,894,013   5,005,759  
         
Total liabilities 8,405,945   6,634,964  
         
Equity        
Ordinary share capital 4,004   3,711  
Share premium 1,744,538   1,319,716  
Capital reserves 250,982   99,311  
Proceeds on account of convertible options 24,858   25,380  
Accumulated profit 322,911   240,023  
Equity attributable to shareholders of the Company 2,347,293   1,688,141  
Non-controlling interests 277,041   306,797  
Total equity 2,624,334   1,994,938  
Total liabilities and equity 11,030,279   8,629,902  

Consolidated Statements of Cash Flows        
  For the nine months ended For the three months ended
  September 30 September 30
  2026 2025 2026 2025
  USD in USD in USD in USD in
  Thousands Thousands Thousands Thousands
         
Cash flows for operating activities        
Profit for the period 102,501 139,629 33,516 32,257
         
Income and expenses not associated with cash flows:        
Depreciation and amortization 146,580 110,159 48,474 39,142
Finance expenses, net 129,654 95,794 44,439 24,721
Share-based compensation 14,995 5,047 4,953 2,053
Taxes on income 33,439 35,083 10,941 9,477
Tax benefits (120,107) (62,059) (40,343) (23,087)
Other income, net (7,003) (5,785) (5,940) (3,411)
Company’s share in losses of investee partnerships 1,709 3,904 288 2,259
Losses (gains) from projects disposals (889) (96,431) – 1,397
  198,378 85,712 62,812 52,551
         
Changes in assets and liabilities items:        
Change in other receivables 507 (2,800) 218 1,793
Change in trade receivables (21,897) (27,365) (1,744) (6,480)
Change in other payables 34,361 28,405 14,730 6,935
Change in trade payables (18,267) (5,418) (4,106) (2,768)
  (5,296) (7,178) 9,098 (520)
         
Income Tax paid (6,513) -10,093 (1,154) (1,420)
         
Net cash from operating activities 289,070 208,070 104,272 82,868
         
Cash flows for investing activities        
Sale (Acquisition) of consolidated entities, net (34,269) 37,832 (19,612) 4,814
Sale of investee entities 29,208 – – –
Changes in restricted cash and bank deposits, net 265,756 (198,170) (15,127) (206,356)
Purchase, development, and construction in respect of projects (2,089,384) (1,163,669) (756,688) (505,647)
Interest receipts (*) 23,147 9,921 7,629 3,587
Loans provided and Investment in investees (46,483) (43,264) (18,163) (16,940)
Repayment of loans to investees 23,951 30,815 1,447 –
Loans provided to non-controlling interests – (297) – (297)
Payments on account of acquisition of consolidated company (11,866) (7,447) (3,992) –
Purchase of long-term financial assets measured at fair value through profit or loss, net (36,223) (5,257) (11,224) (2,010)
Net cash used in investing activities (1,876,163) (1,339,536) (815,730) (722,849)

Consolidated Statements of Cash Flows (Cont.)        
         
  For the nine months ended For the three months ended
  September 30 September 30
  2026 2025 2026 2025
  USD in USD in USD in USD in
  Thousands Thousands Thousands Thousands
         
Cash flows from financing activities        
Receipt of loans from banks and other financial institutions 2,094,229 1,324,524 706,429 649,840
Repayment of loans from banks and other financial institutions (885,425) (407,239) (283,579) (183,878)
Interest paid (*) (103,234) (55,533) (41,409) (15,146)
Issuance of debentures 345,933 125,838 – –
Issuance of convertible debentures – 114,685 – –
Repayment of debentures (184,936) (47,545) (184,936) (25,551)
Dividends and distributions by subsidiaries to non-controlling interests (47,804) (17,326) (9,962) (8,644)
Proceeds from investments by tax-equity investors 239,900 127,695 118,832 127,695
Repayment of tax-equity investment (5,837) (11,590) – (638)
Deferred borrowing costs (52,553) (47,076) (1,143) (458)
Receipt of loans from non-controlling interests 14 182 – –
Repayment of loans from non-controlling interests (6,463) (858) (2,924) (858)
Increase in holding rights of consolidated entity (6,691) (1,392) (6,691) –
Issuance of shares 419,317 290,698 – 290,698
Exercise of share options 37 45 2 15
Repayment of lease liability (6,070) (7,999) (2,303) (2,196)
Proceeds from investment in entities by non-controlling interest 3,347 12,799 3,347 –
         
Net cash from financing activities 1,803,764 1,399,908 295,663 830,879
         
Increase (Decrease) in cash and cash equivalents 216,671 268,442 (415,795) 190,898
         
Balance of cash and cash equivalents at beginning of period 528,497 387,427 1,163,734 480,459
         
Effect of exchange rate fluctuations on cash and cash equivalents (8,836) 23,958 (11,607) 8,470
         
Cash and cash equivalents at end of period 736,332 679,827 736,332 679,827
         
(*) See Appendix 4 for additional information regarding the change in presentation of interest receipts and interest paid.
       

Information related to Segmental Reporting

  For the nine months ended September 30, 2026
  MENA   Europe   USA   Total reportable segments   Others   Total
          USD in thousands        
Revenues 239,928   165,540   102,202   507,670   1,518   509,188
Tax benefits –   –   131,465   131,465   –   131,465
Total revenues and income 239,928   165,540   233,667   639,135   1,518   640,653
                       
Segment adjusted EBITDA 182,690   123,170   211,767   517,627   (874)   516,753
                       
Reconciliations of unallocated amounts:                    
Headquarter costs (*)                     (48,576)
Intersegment profit                     9
Gains from projects disposals (**)                     (28,905)
Depreciation and amortization and share-based compensation               (161,575)
Other expenses not attributed to segments                   (9,340)
Operating profit                     268,366
Finance income                     28,044
Finance expenses                     (158,761)
Share of the losses of equity accounted investees                   (1,709)
Profit before income taxes                     135,940
 
(*) Including general and administrative and development expenses (excluding depreciation and amortization and share based compensation).
(**) Reconciliation between EBITDA and operating profit reflecting the realization of revaluation gains from an asset revalued in 2025.

Information related to Segmental Reporting

  For the nine months ended September 30, 2025
  MENA   Europe   USA   Total reportable segments   Others   Total
          USD in thousands
       
Revenues 173,180   144,503   45,456   363,139   1,272   364,411
Tax benefits –   –   65,493   65,493   –   65,493
Total revenues and income 173,180   144,503   110,949   428,632   1,272   429,904
                       
Segment adjusted EBITDA 160,302   117,429   98,171   375,902   1,092   376,994
                       
Reconciliations of unallocated amounts:                      
Headquarter costs (*)                     (37,776)
Intersegment profit                     172
Gains from projects disposals                     54,597
Depreciation and amortization and share-based compensation               (115,206)
Operating profit                     278,781
Finance income                     36,292
Finance expenses                     (136,457)
Share of the losses of equity accounted investees                   (3,904)
Profit before income taxes                     174,712
 
(*) Including general and administrative and development expenses (excluding depreciation and amortization and share based compensation).
 

Information related to Segmental Reporting

  For the three months ended September 30, 2026
  MENA   Europe   USA   Total reportable segments   Others   Total
          USD in thousands
       
Revenues 98,557   52,220   35,509   186,286   425   186,711
Tax benefits –   –   44,658   44,658   –   44,658
Total revenues and income 98,557   52,220   80,167   230,944   425   231,369
                       
Segment adjusted EBITDA 57,212   37,686   73,689   168,587   526   169,113
                       
Reconciliations of unallocated amounts:                      
Headquarter costs (*)                     (15,178)
Depreciation and amortization and share-based compensation               (53,427)
Other expenses not attributed to segments                     (9,340)
Operating profit                     91,168
Finance income                     7,784
Finance expenses                     (54,207)
Share of the losses of equity accounted investees                     (288)
Profit before income taxes                     44,457
 
(*) Including general and administrative and development expenses (excluding depreciation and amortization and share based compensation).
 

Information related to Segmental Reporting

  For the three months ended September 30, 2025
  MENA   Europe   USA   Total reportable segments   Others   Total
          USD in thousands
       
Revenues 77,543   45,319   15,448   138,310   226   138,536
Tax benefits –   –   26,521   26,521   –   26,521
Total revenues and income 77,543   45,319   41,969   164,831   226   165,057
                       
Segment adjusted EBITDA 53,271   35,203   38,258   126,732   13   126,745
                       
Reconciliations of unallocated amounts:                    
Headquarter costs (*)                     (14,818)
Intersegment profit                     45
Losses from projects disposals                     (739)
Depreciation and amortization and share-based compensation               (41,195)
Operating profit                     70,038
Finance income                     28,126
Finance expenses                     (54,171)
Share of the losses of equity accounted investees                   (2,259)
Profit before income taxes                     41,734
 
(*) Including general and administrative and development expenses (excluding depreciation and amortization and share based compensation).

Appendix 2 – Reconciliations between Net Income to Adjusted EBITDA

($ thousands) For the nine months For the three months
    ended September 30 ended September 30
    2026 2025 2026 2025
Net Income 102,501 139,629 33,516 32,257
Depreciation and amortization   146,580 110,159 48,474 39,142
Share based compensation   14,995 5,047 4,953 2,053
Finance income (28,044) (36,292) (7,784) (28,126)
Finance expenses 158,761 136,457 54,207 54,171
Gain (losses) from project disposals   (889) (96,431) – 1,397
Contribution from project sales (*)   29,794 41,834 – (658)
Non-recurring other expenses, net (**)   9,340 – 9,340 –
Share of losses of equity accounted investees   1,709 3,904 288 2,259
Taxes on income 33,439 35,083 10,941 9,477
Adjusted EBITDA 468,186 339,390 153,935 111,972
           
* Contribution to Adjusted EBITDA from the sales of a stake in a deconsolidated asset (Sunlight cluster). For further information regarding the composition of Adjusted EBITDA, refer to the description appearing in the “Non-IFRS financial measures” section of this press release.
           
** For the purposes of calculating the Adjusted EBITDA, payment of PPA cancellation fees, and compensation and an advance payment refund from a supplier not part of the Company’s core business (which are unrelated to contractual performance shortfalls) are recognized as Non-recurring other expenses, net.
 

Appendix 3 – Debentures Covenants 

Debentures Covenants 

As of September 30, 2026, the Company was in compliance with all of its financial covenants under the indenture for the Series C, D, G and H Debentures, based on having achieved the following in its consolidated financial results:  

Minimum equity 

The company’s equity shall be maintained at no less than NIS 1,250 million so long as debentures C and D remain outstanding, and USD 600 million so long as debentures G and H remain outstanding. 

As of September 30, 2026, the company’s equity amounted to NIS 8,038 million (USD 2,624 million). 

 Net financial debt to net CAP 

The ratio of standalone net financial debt to net CAP shall not exceed 65% for two consecutive financial periods so long as debentures C, D, G and H remain outstanding. 

As of September 30, 2026, the net financial debt to net CAP ratio, as defined above, stands at 32%. 

Net financial debt to EBITDA 

For as long as debentures C and D remain outstanding, the consolidated financial debt to EBITDA ratio shall not exceed 15 for more than two consecutive financial periods. 

For as long as debentures G and H remain outstanding, the consolidated financial debt to EBITDA ratio shall not exceed 17 for more than two consecutive financial periods. 

As of September 30, 2026, the net financial debt to EBITDA ratio, as defined above, stands at 5.3.

 Equity to balance sheet 

The standalone equity to total balance sheet ratio shall be maintained at no less than 25% and 28%, respectively, for two consecutive financial periods for as long as debentures C and D and debentures G and H remain outstanding. 

As of September 30, 2026, the equity to balance sheet ratio, as defined above, stands at 62%. 

Appendix 4 – Change in accounting policy 

Until September 30, 2025, interest paid and interest received were presented within cash flows from operating activities in the Consolidated Statements of Cash Flows. In accordance with IAS 7 Statement of Cash Flows, entities are permitted to classify interest paid and interest received as operating, investing, or financing cash flows, provided that the selected classification is applied consistently from period to period.

During the fourth quarter of 2025, management elected to change the classification of interest paid, including payments relating to interest rate swap (IRS) instruments to cash flows used in financing activities, and interest received to cash flows from investing activities. Management believes that this change in presentation provides a more comprehensive view of the cost of financing the Company’s operations and better reflects management’s view of the financing nature of these transactions.

Accordingly, comparative information has been retrospectively adjusted to reflect this change in accounting policy in the Consolidated Statements of Cash Flows, as presented below:

($ thousands) For the nine months ended
    September 30, 2025
    As reported Adjustment As adjusted
Net cash from operating activities   162,458 45,612 208,070
Net cash used in investing activities   (1,349,457) 9,921 (1,339,536)
Net cash from financing activities   1,455,441 (55,533) 1,399,908
Increase in cash and cash equivalents   268,442 – 268,442

($ thousands) For the three months ended
    September 30, 2025
    As reported Adjustment As adjusted
Net cash from operating activities   71,309 11,559 82,868
Net cash used in investing activities   (726,436) 3,587 (722,849)
Net cash from financing activities   846,025 (15,146) 830,879
Increase in cash and cash equivalents   190,898 – 190,898
         

Appendix 5

 a) Segment information: Operational projects

($ thousands)     9 Months ended September 30 3 Months ended September 30
Operational
Project
Segments
Installed
Capacity
(MW)
  Installed
Storage
(MWh)
Generation
(GWh)
  Revenues and
income
  Segment Adjusted
EBITDA1
Generation
(GWh)
  Reported Revenue   Segment Adjusted
EBITDA1
        2026   2025   2026   2025   2026   2025 2026   2025   2026   2025   2026   2025
MENA 676   899 1,161   1,158   239,928   173,180   149,651   115,514 395   463   98,557   77,544   57,212   51,127
Europe 1,351   75 2,085   1,912   165,541   144,502   123,170   117,428 602   559   52,220   45,318   37,686   35,202
USA 896   2,540 1,536   790   233,667   110,948   211,767   98,171 523   271   80,168   41,968   73,688   38,258
Total
Consolidated
2,923   3,514 4,782   3,860   639,136   428,630   484,588   331,113 1,520   1,293   230,945   164,830   168,586   124,587
Unconsolidated
at Share
32   80                                            
Total 2,955   3,594                                            


b) Operational Projects Further Detail

($ thousands)     9 Months ended September 30, 2026 3 Months ended September 30, 2026
   
Operational Project Segment Installed
Capacity
(MW)
Installed
Storage
(MWh)
Revenues and
income
Segment
Adjusted
EBITDA1
Reported Revenue Segment
Adjusted
EBITDA1
Debt balance as of September 30, 2026 Ownership %2
MENA Wind MENA 316 – 82,217   25,472   604,856 49%
MENA PV MENA 360 899 157,711   73,085   619,666 84%
Total MENA 676 899 239,928 149,651 98,557 57,212 1,224,522  
Europe Wind Europe 1,184 – 149,207   45,213   807,853 65%
Europe PV Europe 167 75 16,334   7,007   69,121 74%
Total Europe 1,351 75 165,541 123,170 52,220 37,686 876,974  
USA PV USA 896 2,540 233,667   80,168   678,261 100%
Total USA   896 2,540 233,667 211,767 80,168 73,688 678,261  
Total Consolidated Projects   2,923 3,514 639,136 484,588 230,945 168,586 2,779,757  
Uncons. Projects at share   32 80           50%
Total   2,955 3,594 639,136 484,588 230,945 168,586 2,779,757  
                   

1) For the 9 month ended September 2026, EBITDA included $1.9m of compensation recognized from Bjorenberget and excluded $30m from Sunlight sale and $3m of compensation from Emek; For the 9 month ended September 2025 EBITDA excluded $42m from Sunlight sale

2) Ownership % is calculated based on the project’s share of total revenues 

c) Projects under construction

($ millions)
Consolidated Projects
Country Generation and energy storage Capacity (MW/MWh) Est.
COD
Est. Total
Project Cost
Tax credit benefit- Qualifying category Tax credit benefit- Adders3 Discounted Value of Tax Benefit2 Est. Total
Project Cost net of tax benefit
Capital Invested as of September 30, 2026 Est. Equity Required (%) Equity Invested as of September 30, 2026 Est. First Full Year Revenue4 Est. First Full Year EBITDA4,5 Ownership
%1
Country Acres USA 403/688 Q4 2026 814-855 ITC DC (10%) 399-419 415-436 780 0%-10%6 94 62-65 48-50 100%
Co Bar Complex USA 1,211/4,000 Q4 2027-
H1 2028
2,938-3,089 ITC, PTC EC (10%) +
DC (10%
BESS only)
1,434-
1,508
1,504-
1,581
834 0%-
10%6
348 244-
257
195-
205
100%
Crimson Orchard USA 120/400 Q2 2027 298-313 ITC EC (10%)11 138-145 160-168 193 0%-10%6 34 27-28 20-21 100%
Snowflake A USA 594/1,900 Q4 2027 1,353-1,422 ITC EC (10%)11 605-636 748-786 1,021 0%-10%6 159 124-130 104-109 100%
Finland BESS10 Finland 0/902 H1 2028 144-151 – – – 144-151 14 25%-35% 14 43-45 29-31 51%
Bertikow Germany 0/881 H1 2028 176-185 – – – 176-185 20 20%-30% 20 36-38 31-32 50%
Gecama Solar Spain 227/220 Q4 2026 196-206 – – – 196-206 159 23%-28%7 150 36-38 29-31 72%
Tapolca Bess Hungary 0/140 Q4 26 24-25 – – – 24-25 16 40%-50% 16 7 6-7 100%
Bjornberget – BESS Sweden 0/100 Q1 2027 24-25 – – – 24-25 19 100% 19 4 3 55%
Ohad HV storage9 Israel 0/675 H2 2028 118-124 – – – 118-124 14 10%-20% 14 9 5 100%
Israel Construction Israel 37/326 H1 27-
H2 28
85-90 – – – 85-90 22 15%-25% 22 15-16 7-8 85%
Total Consolidated Projects   2,592/
10,232
  6,170-
6,485
    2,576-
2,708
3,594-
3,777
3,093   890 607-
637
477-
502
 
Unconsolidated Projects at share10 Israel 7/137 Q4 2026-
H2 2027
27-28 – – – 27-28 22 15%-20% 22 5-6 4 53
Total   2,599/
10,369
  6,197-
6,513
    2,576-
2,708
3,621-
3,805
3,115   912 612-
643
481-
506
 
                             

d) Pre-Construction Projects (due to commence construction within 12 months of the Approval Date)

($ millions)
Consolidated Projects
Country Generation and energy storage Capacity (MW/MWh) Est.
COD
Est. Total
Project Cost
Tax Credit Benefit Discounted Value of Tax Benefit2 Est. Total Project Cost net of tax benefit Capital Invested as of September 30, 2026 Est. Equity Required (%) Equity Invested as of September 30, 2026 Est. First Full Year Revenue4 Est. First Full Year EBITDA4,5 Ownership %1
Qualifying Category Adders3
                             
Nardo Italy 104/872 2029 232-244 – – – 232-244 11 25%-35% 11 44-46 36-38 100%
Jupiter Germany 150/2,166 H2 2028 536-563 – – – 536-563 8 30%-40% 8 95-99 78-82 51%
Karpen Romania 0/848 H2 2028-H1 2029 153-161 – – – 153-161 7 25%-35% 7 31-33 26-27 100%
Finland BESS Finland 0/1,400 H1 2028 237-249 – – – 237-249 26 25%-35% 26 62-65 42-44 100%
Mosciska Poland 0/216 H2 2028 50-52 – – – 50-52 5 30%-40% 5 16-17 13-14 100%
Neot Smadar HV storage9 Israel 0/675 H1 2029 117-123 – – – 117-123 0 10%-20% 0 7 3 100%

($ millions)
Additional
Pre-Construction
Projects
MW Deployment
MW/MWh
Est. Total
Project Cost
Tax Credit Benefit Discounted Value of
Tax Benefit2
Est.
Total
Project
Cost net
of tax
benefit
Capital
Invested
as of September 30,
2026
Est.
Equity Required
(%)
Equity
Invested
as of
September 30
2026
Est.
First Full Year Revenue4
Est.
First Full
Year
EBITDA4,5
Ownership
%1
2027 2028 2029 Qualifying Category Adders3
United States 128/0 184/0 255/0 1,008-1,059 ITC DC
(10%) &
EC
(10%)8
488-513 520-546 64 15%-35% 64 64-68 49-51 100%
Europe 0/75 0/429 – 93-98 – – – 93-98 5 30%-100% 5 20-21 15-16 86%
MENA 0/75 74/945 – 284-298 – – – 284-298 13 20%-40% 13 59-62 32-34 93%
Total
Consolidated
Projects
128/150 258/1,374 255/0 2,710-2,847     488-513 2,222-2,334 139   139 398-419 294-309  
Unconsolidated
Projects at share10
0/26 0/22 – 6 – – – 6 1 15%-20% 1 1-2 1 54%
Total
Pre-Construction
895MW +7,749MWh 2,716-2,853     488-513 2,228-2,340 140   140 399-420 295-310  
                           

1) The legal ownership share for all U.S. projects is 90%, but Enlight invests 100% of the equity in the project and entitled to 100% of the project distributions until full repayment of Enlight’s capital plus a preferred return

2) Value of tax benefits under the IRA: The PTC value is estimated based on the project’s expected annual production and a yearly CPI indexation of 2%, discounted by 8% to COD. In assessing the value of the ITC, a step-up adjustment was made to reflect the full value of the tax credits, thus lowering net construction costs and enhancing the valuation and return of the project. The actual value attributed to tax benefits in a tax equity transaction may differ from the value presented, subject to the structure of the transaction and prevailing market conditions.

3) The Energy Community (EC) Adder provides extra credits for renewable energy projects in areas impacted by fossil fuel reliance or economic transition. The Domestic Content (DC) Adder rewards projects using U.S.-manufactured components, promoting local job creation and supply chain growth

4) Revenue and EBITDA for the first year of U.S. projects as presented above do not include income from tax benefits

5) EBITDA is a non-IFRS financial measure. This figure represents consolidated EBITDA for the project and excludes the share of project distributions to tax equity partners, as well as ITC and PTC proceeds. These components of the tax equity transaction may differ from project to project, are subject to market conditions and commercial terms agreed upon reaching financial close 

6) The required equity during construction is estimated at 10% and is expected to decrease to 0% at COD

7) The majority of Gecama Solar’s equity is funded through debt held at Gecama Wind, amounting to $129m as of September 30, 2026. This debt is included in Gecama Wind’s debt balance under the operational projects.

8) Rustic hills 1+2 – DC (10%) + EC (10%); Coggon – DC (10%); Gemstone – DC (10%);

9) Two high voltage projects with total capacity of 1,350MWh. Estimated revenue for the first 5 years is $16m million per year. From year 6, the projects will move to a deregulated market, with revenue expected to be $36 million per year

10) All numbers, beside equity invested, reflects Enlight share only

11) In the previous quarter, the Snowflake A BESS project was presented as expected to be eligible for the Domestic Content (“DC”) Adder. The project will not meet the applicable requirements for the DC adder. However, the removal of the DC adder is offset by significant savings capital expenditure of the new alternative equipment resulting in a negligible impact on the project’s economics

e) Additional information on tax equity investments

    Tax equity investment

Tax equity partner’s share of project tax credits, cash flows, and taxable income
($ millions)
Projects*
Est. Total
Project Cost
Upfront tax equity investment Tax credit proceeds during the project’s operation (“pay-go”) Share of ITC/PTC tax credit allocated to tax equity partner Share of taxable income initial period Duration of initial period for share of taxable income (years) Share in project cash flow initial period (second period) Duration of initial period for share in project cash flow (years)
Atrisco PV 369 198 55 Confidential Confidential Confidential 17.5% (5%) 10
Atrisco BESS 458 266 – Confidential Confidential Confidential 23% (7%) 5
Quail Ranch 274 131 18 99% 99% 10 10% (5%) 10
Roadrunner 621 337 55 99% 99% 10-May 10%-12% (5%) 10
                 
* Apex financing was structured as a sale and leaseback and therefore not included in the table above
                 

Appendix 6 – cash and cash equivalents

($ thousands) September 30, 2026
Cash and Cash Equivalents:  
Enlight Renewable Energy Ltd, Enlight EU Energies Kft and Enlight Renewable LLC excluding subsidiaries (“Topco”) 420,357
Subsidiaries 315,975
Deposits:  
Short term deposits –
Restricted Cash:  
Projects under construction 153,628
Reserves, including debt service, performance obligations and others 118,407
Total Cash 1,008,367
   

Appendix 7 – Corporate level (TopCo) debt

($ thousands) September 30, 2026
Debentures:
Debentures 831,960*
Convertible debentures 276,155
Loans from banks and other financial institutions:
Credit and short-term loans from banks and other financial institutions 54,294
Loans from banks and other financial institutions 116,732
Total corporate level debt 1,279,141
* Including current maturities of debentures in the amount of 192,130

Appendix 8 – Functional Currency Conversion Rates:

The financial statements of each of the Company’s subsidiaries were prepared in the currency of the main economic environment in which it operates (hereinafter: the “Functional Currency”). For the purpose of consolidating the financial statements, results and financial position of each of the Group’s member companies are translated into the Israeli shekel (“NIS”), which is the Company’s Functional Currency. The Group’s consolidated financial statements are presented in U.S. dollars (“USD”).

FX Rates to USD:

  Date of the financial statements:   Euro NIS
  As of 30th September 2026   1.13 0.33
  As of 30th September 2025   1.17 0.3
         
  Average for the 3 months period ended:      
  September 2026   1.15 0.33
  September 2025   1.17 0.3
         

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/771aee0b-1905-4c68-88b2-4b6bff3d4fb4

Download a photo of Hopscotch Public Engagement Management.

Photo of Mélanie Rouchy, Nicolas Balland, Caroline Danloy and Sylvain Rouchy.
Photo of Mélanie Rouchy, Nicolas Balland, Caroline Danloy and Sylvain Rouchy.

Press release
Paris, November 3rd 2026

Hopscotch launches Hopscotch Public Engagement, a new entity dedicated to the European institutions

The communications Group is combining its integrated expertise and international network to support the EU institutions meet their communication challenges and the demands of major public contracts.

HOPSCOTCH, the international communications Group founded in France, today announces the launch of Hopscotch Public Engagement. The new Brussels-based entity will primarily serve the EU institutions and, more broadly, the European public sector.

The launch reflects the Group’s ambition to strengthen its presence with the EU institutions. Much of their communication work is commissioned through multi-year framework contracts spanning several areas of expertise and several countries. Hopscotch Public Engagement will meet these needs by drawing on the strengths of an integrated communications group: specialist expertise, sector knowledge and the ability to deliver across Europe.

An integrated offer built for the challenges of public communication

From 360° communication campaigns to events, digital, influence and public relations, Hopscotch Public Engagement brings together the Group’s expertise to design and deliver communication strategies suited to the complexity of EU issues. This integrated approach meets the wide range of the institutions’needs. It is also built for framework contracts, which are typically split into multiple lots and require several disciplines and teams to work in close coordination.

The entity builds on the experience HOPSCOTCH has developed with private- and public-sector clients, adapting it to the conventions and requirements of EU institutional communication. This includes the Group’s approaches to Relational Capital and augmented public relations, which help institutions explain their work, strengthen dialogue with their audiences and deliver their messages at the right time.

The offer relies on the Group’s sector expertise and international network. As an independent European group, HOPSCOTCH has more than 40 offices worldwide. Its organisation is designed to support pan-European campaigns and to coordinate communication programmes across European markets.

The Group also draws on the experience of its international network, formerly Sopexa, in supporting regulated sectors and European programmes for agriculture and food industry players. It also runs international campaigns on behalf of the European Commission’s Directorate-General for Agriculture and Rural Development (DG AGRI) and the European Research Executive Agency (REA).

“The launch of Hopscotch Public Engagement reflects a conviction the Group holds firmly: the biggest communication challenges now play out at European level. With this new entity, we are combining in-depth knowledge of the institutions with our network’s ability to coordinate programmes across European and international markets,” says Sylvain Rouchy, Vice President, Global Operations at HOPSCOTCH.

Based in Brussels, Hopscotch Public Engagement works alongside Hopscotch Belgium, the Group’s brand communication agency for the Belgian market, led by Mélanie Rouchy.

“Setting up Hopscotch Public Engagement in Brussels is a great opportunity to strengthen synergies within the Group and to put our complementary expertise at the service of the European institutions,” says Mélanie Rouchy, Managing Director of Hopscotch Belgium.

A shared ambition to serve Europe

Hopscotch Public Engagement is co-led by Caroline Danloy and Nicolas Balland. Between them, they bring knowledge of the European institutions, communications expertise and experience in leading multidisciplinary teams.

Caroline Danloy has extensive experience in strategic communication for international and European institutional clients. Over a 25-year career, she has served as Vice President at ICF Next, where she led 360° communication teams delivering major European campaigns.

“We are at a turning point for European democracy. Communicating about the work of the European institutions and the challenges they face is more important than ever, and it is a mission I have been proud to carry out for 25 years,” says Caroline Danloy, Co-Managing Director of Hopscotch Public Engagement.

“Hopscotch brings a rare combination to this market: the scale and maturity of an international network headquartered in France, expertise spanning the public and private sectors, and real depth of subject knowledge. Communicating for public institutions involves many topics and stakeholders, and this combination is exactly what that complexity demands. Alongside Nicolas, whose experience I know well, I look forward to putting these strengths at the service of the European institutions with Hopscotch Public Engagement.”

Nicolas Balland brings more than 20 years of experience in the communications industry, particularly in events, public relations and institutional communication. After holding various roles at ICF Next, he joined Tipik, where he led Event, Studio and Audiovisual teams before becoming Managing Director.

“This is a project Caroline and I had been thinking about for several years. When we met Hopscotch, we quickly realised that we shared the same ambition,” explains Nicolas Balland, Co-Managing Director of Hopscotch Public Engagement.

“Today, we are proud to offer the European institutions the strength of a leading communications Group, combined with distinctive expertise and in-depth knowledge of European issues. Our ambition goes beyond designing and delivering communication campaigns: we want to build an organisation that connects institutions, citizens and ideas, and that takes concrete action for Europe.”

—
Press contact
Olivier Duval

+337 64 42 39 06

oduval@hopscotch.one

About HOPSCOTCH  

HOPSCOTCH is an international communications Group founded in France, driven by an entrepreneurial vision and the complementary nature of its talents and expertise. 
HOPSCOTCH is a unique combination of expertise, driven by the belief that the value of a company or organisation lies in the quality of its Relational Capital. 
With more than 1,200 employees, half of whom are based internationally (40 offices across 5 continents), HOPSCOTCH covers all areas of communication: influence, events, public relations, activations, digital, internal communication, public affairs, and marketing services. 
HOPSCOTCH organises its agencies around its areas of expertise: 
Event: Hopscotch Event, Hopscotch Congrès, Hopscotch Moments, Sagarmatha. 
Public Relations: Hopscotch PR, Le Public Système PR, Human to Human, Hopscotch Décideurs.  
Digital and Marketing: heaven, AD Crew, Hopscotch Digital Studio, Sublime. 
Media: Hopscotch Media 
Sectorial expertise: Hopscotch Cinéma, Hopscotch Luxe, Hopscotch Season, Hopscotch Sport, Hopscotch Tourism. 
HOPSCOTCH has been committed to ambitious ecological and societal initiatives for over 15 years, validated by internationally recognized CSR certifications, including RSE Agences Actives, ISO 20121, and the EcoVadis Gold medal. 

In 2026, HOPSCOTCH was named “Global Agency of the Year” by PRovoke Media. 
Listed on Euronext Growth Paris (Ticker code: ALHOP FR ; ISIN code: FR 00000 6527 8), the Group represents a turnover of €270,8 million and a gross margin of €98,8 million in 2025.  
Follow us: www.hopscotch.one and on LinkedIn / X / Instagram / Bluesky @HOPSCOTCHGroupe 

Attachments

Volta Finance Limited (VTA/VTAS)

Notification of transactions by directors, persons discharging managerial
responsibilities and persons closely associated with them

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

*****
Guernsey, 03 November 2026

Pursuant to the announcements made on 5 April 2019 and 26 June 2020 relating to changes to the payment of directors fees and in line with the Company’s current Remuneration Policy, Volta Finance Limited (the “Company” or “Volta”) has purchased 4,727 ordinary shares of no par value in the Company (“Ordinary Shares”) at an average price of €5.96 per share.

Each director receives 30% of their Director’s fees for any year in the form of shares, which they are required to retain for a period of no less than one year from their respective date of issue.

The shares will be issued to the Directors, who for the purposes of Regulation (EU) No 596/2014 on Market Abuse (“MAR“) are “persons discharging managerial responsibilities” (a “PDMR“).

  • Dagmar Kershaw, Chairman and a PDMR for the purposes of MAR, acquired 1,438 additional Ordinary Shares in the Company. Following the settlement of this transaction, Ms Kershaw will have an interest in 42,577 Ordinary Shares, representing 0.12% of the issued shares of the Company;
  • Yedau Ogoundele, Director and a PDMR for the purposes of MAR acquired 1,007 additional Ordinary Shares in the Company. Following the settlement of this transaction, Mrs Ogoundele will have an interest in 14,381 Ordinary Shares, representing 0.04% of the issued shares of the Company;
  • Joanne Peacegood, Director and a PDMR for the purposes of MAR acquired 1,222 additional Ordinary Shares in the Company. Following the settlement of this transaction, Mrs Peacegood will have an interest in 12,633 Ordinary Shares, representing 0.03% of the issued shares of the Company; and
  • Simon Holden, Director and a PDMR for the purposes of MAR acquired 1,060 additional Ordinary Shares in the Company. Following the settlement of this transaction, Mr Holden will have an interest in 9,353 Ordinary Shares, representing 0.03% of the issued shares of the Company.

The notifications below, made in accordance with the requirements of MAR, provide further detail in relation to the above transactions:

  1. Details of the person discharging managerial responsibilities / person closely associated
a) Dagmar Kershaw
CHAIRMAN & DIRECTOR
b) Yedau Ogoundele
DIRECTOR
c) Joanne Peacegood
DIRECTOR
d) Simon Holden
DIRECTOR
  1. Reason for the notification
a. Position/status Director
b. Initial notification/Amendment Initial notification
  1. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name Volta Finance Limited
b. LEI 2138004N6QDNAZ2V3W80
  1. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of financial instrument, type of instrument Ordinary Shares
b. Identification code GG00B1GHHH78
c. Nature of the transaction Purchase and allocation of Ordinary Shares relation to the part-payment of Directors’ fees for the quarter ended 31 October 2026
d. Price(s) €5.96 per share
e. Volume(s) Total: 4,727
f. Date of transaction 2 November 2026
g. Place of transaction On-market – London
  1. Aggregate Purchase Information
a) Dagmar Kershaw
Chairman and Director
b) Yedau Ogoundele Director c) Joanne Peacegood
Director
d) Simon Holden
Director
Aggr. Volume:
1,438

Price:
€5.96 per share

Aggr. Volume:
1,007

Price:
€5.96 per share

Aggr. Volume:
1,222

Price:
€5.96 per share

Aggr. Volume:
1,060

Price:
€5.96 per share

CONTACTS

For the Investment Manager
BNP Paribas Asset Management Europe

Matthieu Laurence
matthieu.laurence@axa-im.com
+33 (0) 1 44 45 88 82

Olivier Pons
Olivier.pons@axa-im.com
+33 (0) 1 44 45 87 30

Company Secretary and Administrator

BNP Paribas S.A, Guernsey Branch
guernsey.bp2s.volta.cosec@bnpparibas.com 
+44 (0) 1481 750 850

Corporate Broker
Cavendish Securities plc
Andrew Worne
Daniel Balabanoff
+44 (0) 20 7397 8900

*****
ABOUT VOLTA FINANCE LIMITED

Volta Finance Limited is incorporated in Guernsey under The Companies (Guernsey) Law, 2008 (as amended) and listed on Euronext Amsterdam and the London Stock Exchange’s Main Market for listed securities. Volta’s home member state for the purposes of the EU Transparency Directive is the Netherlands. As such, Volta is subject to regulation and supervision by the AFM, being the regulator for financial markets in the Netherlands.

Volta’s Investment objectives are to preserve its capital across the credit cycle and to provide a stable stream of income to its Shareholders through dividends that it expects to distribute on a quarterly basis. The Company currently seeks to achieve its investment objectives by pursuing exposure predominantly to CLO’s and similar asset classes. A more diversified investment strategy across structured finance assets may be pursued opportunistically. The Company has appointed BNP Paribas Asset Management Europe an investment management company with a division specialised in structured credit, for the investment management of all its assets.

*****

This press release is published by BNP Paribas Asset Management Europe (“BNPP AM”), in its capacity as alternative investment fund manager (within the meaning of Directive 2011/61/EU, the “AIFM Directive”) of Volta Finance Limited (the “Volta Finance”) whose portfolio is managed by BNPP AM.

This press release is for information only and does not constitute an invitation or inducement to acquire shares in Volta Finance. Its circulation may be prohibited in certain jurisdictions and no recipient may circulate copies of this document in breach of such limitations or restrictions. This document is not an offer for sale of the securities referred to herein in the United States or to persons who are “U.S. persons” for purposes of Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or otherwise in circumstances where such offer would be restricted by applicable law. Such securities may not be sold in the United States absent registration or an exemption from registration from the Securities Act. Volta Finance does not intend to register any portion of the offer of such securities in the United States or to conduct a public offering of such securities in the United States.

*****

This communication is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The securities referred to herein are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Past performance cannot be relied on as a guide to future performance.

*****
This press release contains statements that are, or may deemed to be, “forward-looking statements”. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “believes”, “anticipated”, “expects”, “intends”, “is/are expected”, “may”, “will” or “should”. They include the statements regarding the level of the dividend, the current market context and its impact on the long-term return of Volta Finance’s investments. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. Volta Finance’s actual results, portfolio composition and performance may differ materially from the impression created by the forward-looking statements. BNPP AM does not undertake any obligation to publicly update or revise forward-looking statements.

Any target information is based on certain assumptions as to future events which may not prove to be realised. Due to the uncertainty surrounding these future events, the targets are not intended to be and should not be regarded as profits or earnings or any other type of forecasts. There can be no assurance that any of these targets will be achieved. In addition, no assurance can be given that the investment objective will be achieved.

The figures provided that relate to past months or years and past performance cannot be relied on as a guide to future performance or construed as a reliable indicator as to future performance. Throughout this review, the citation of specific trades or strategies is intended to illustrate some of the investment methodologies and philosophies of Volta Finance, as implemented by BNPP AM. The historical success or BNPP AM’s belief in the future success, of any of these trades or strategies is not indicative of, and has no bearing on, future results.

The valuation of financial assets can vary significantly from the prices that the BNPP AM could obtain if it sought to liquidate the positions on behalf of the Volta Finance due to market conditions and general economic environment. Such valuations do not constitute a fairness or similar opinion and should not be regarded as such.

Editor: BNP PARIBAS ASSET MANAGEMENT Europe, a company incorporated under the laws of France, having its registered office located at 1 boulevard Haussmann – 75009 Paris, registered with the Paris Trade and Companies Register under number 319 378 832, and a Portfolio Management Company, holder of AMF approval no. GP 96002, issued on 19 April 1996.

*****

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.